ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000229.1|Grincamycin_1 # 1 # 600 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.767	BGC0000229.1|Grincamycin_1 	1	600	+	Loose	400	28.8758	ErmX	42.0	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGGACGACGAGAACCGGGTGGCCGGCCTGCTGCTGGCCGCGGGCGGCGGACGACGGCTCGGCGGGCGCCCCAAGGGGCTGCTCCCCCACCGGGGGCGGCTCCTCGTGGAGCACGCGGCGGAGGTGCTGCGCGCGGGCGGCTGCGCGAGCGTGCACGTGGTGCTGGGGGCGCGCGCCGAGGAGGTGCGCGCCCGCGCGGCGCTGCCGGACTGCGCGCTCATCGACAACCCGGACTGGGAGCAGGGCATGGGCACGTCCTTGCGGGCCGGGCTGACCGCGCTCGCCGGCACGGGCGCGCGGGCCGCGCTCGTACTGCTGGTGGACCAGCCGGGGATCGGCGCGGAGGCGGTGGCCCGGGTGCGGCGCGCGTACCGGTCGCCGCGCTCGCTGGTCTCGGCGGCGTACGACGGCGTCCGCGGGCATCCGGTGCTGTTCGGCGCCGAGCACTGGGCGGGGATCGCCGCGACCGCCACGGGCGACCAGGGCGCACGCGCCTACCTCAAGGAGCACGCGGACGCCGTGGAACTGGTCGAGTGCGGTGATGTCGCGGAGGCGTACGACATCGACACGGAGGCCGATCTGACGCACCTTGAATGA	MTDDENRVAGLLLAAGGGRRLGGRPKGLLPHRGRLLVEHAAEVLRAGGCASVHVVLGARAEEVRARAALPDCALIDNPDWEQGMGTSLRAGLTALAGTGARAALVLLVDQPGIGAEAVARVRRAYRSPRSLVSAAYDGVRGHPVLFGAEHWAGIAATATGDQGARAYLKEHADAVELVECGDVAEAYDIDTEADLTHLE	MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR	70.07	gnl|BL_ORD_ID|872|hsp_num:0	950			630	777	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000229.1|Grincamycin_2 # 763 # 2388 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000229.1|Grincamycin_2 	763	2388	+	Loose	500	30.8018	TEM-194	31.34	3001054	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGTCCGCACCAGCGCCGTCCCCGCTGGCCATCGTCGACGCCGAGCCCCTGCCGCGGCAGGAGGAGGTCCTCTCCGAGACGGCCCTCGCCTTCCTGGCGGAGCTGCACCGCCGGTTCACGCCCCGGCGCGACGACTTGCTCGCCCGGCGCGCGGAGCGCCGCGCCGAGATCGCCCGCACCTCCACCCTCGACTTCCTCCCGGAGACGGCCGCGATCCGCGCCGACGACTCCTGGAAGGTCGCCCCGGCCCCGCCGGCCCTGGAGGACCGCCGCGTCGAGATCACCGGCCCGACCGACCGCAAGATGACCATCAACGCGCTGAACTCCGGCGCCAAGGTGTGGCTCGCGGACTTCGAGGACGCGTCCGCGCCCACCTGGGAGAACGTGGTCACCGGCCAGCTCAACCTGATCGACGCCTACACCCGCCGCATCGACTTCACCGACGAGCGCACGGGCAGGACGTACGCCCTGCGGCCGGACGAGGAGCTGGCGACGGTCGTCATGCGCCCGCGCGGCTGGCACCTGGACGAGCGCCACCTCACCGGCCCCGACGGCACCCCGGTGCCCGGCGCTTTGGTCGACTTCGGCCTGTACTTCTTCCACAACGCCCAGCGGCTGCTCGACCTCGGCAAGGGCCCGTACTTCTACCTGCCGAAGACGGAGTCGCACCTCGAGGCGCGGCTGTGGAACGACGTGTTCGTGTTCGCGCAGGACTACCTGGGCATCCCCCAGGGCACCGTCCGCGCCACGGTCCTCATCGAGACGATCACCGCCGCGTACGAGATGGAGGAGATCCTCCACGAGCTGCGCGACCACGCGTCCGGGCTGAACGCGGGCCGCTGGGACTACCTGTTCTCCATCGTCAAGAACTTCCGCGACGGCGGGCCGAAGTTCGTGCTGCCGGACCGCAACGCGGTGACGATGACCGCCCCGTTCATGCGGGCGTACACCGAACTCCTCGTCCGCACCTGCCACAAGCGCGGCGCGCACGCGATCGGCGGCATGGCGGCGTTCATCCCGTCCCGGCGGGACGAGGAGGTCAACAAGGTCGCCTTCGAGAAGGTGAAGGCGGACAAGGACCGCGAGGCGAACGACGGGTTCGACGGCTCGTGGGTCGCCCACCCGGACCTGGTGCCGATCGCGATGGAGTCCTTCGACCGGGTGCTCGGCGACCGGCCGAACCAGAAGGACCGGCTGCGCGAGGACGTCGACGTCAAGGCCGAGGACCTGATCGCGATCGACTCGCTCGACGCCAGGCCCACGTACGCGGGTCTGGTCAACGCCGTGCAGGTCGGCATCCGTTACATCGAGGCGTGGCTGCGCGGCCTGGGCGCGGTGGCCATCTTCAATCTGATGGAGGACGCGGCCACCGCGGAGATCTCCCGCTCCCAGATCTGGCAGTGGATCAACGCGGGCGTCGTCCTCGACAACGGCGAGAAGGTCACCGCCGAGCTGGCCCGCAAGGTCGCCGCCGAGGAACTGGCGGACATCCGCGCGGAGATCGGCGAGGAGGCGTTCGCTGCGGGCAACTGGCAGCAGGCCCACGACCTGCTGCTGAAGGTCGCCCTCGACGAGGACTACGCGGACTTCCTCACGCTTCCGGCGTACGAGCAGCTCAAGGGCTGA	MSAPAPSPLAIVDAEPLPRQEEVLSETALAFLAELHRRFTPRRDDLLARRAERRAEIARTSTLDFLPETAAIRADDSWKVAPAPPALEDRRVEITGPTDRKMTINALNSGAKVWLADFEDASAPTWENVVTGQLNLIDAYTRRIDFTDERTGRTYALRPDEELATVVMRPRGWHLDERHLTGPDGTPVPGALVDFGLYFFHNAQRLLDLGKGPYFYLPKTESHLEARLWNDVFVFAQDYLGIPQGTVRATVLIETITAAYEMEEILHELRDHASGLNAGRWDYLFSIVKNFRDGGPKFVLPDRNAVTMTAPFMRAYTELLVRTCHKRGAHAIGGMAAFIPSRRDEEVNKVAFEKVKADKDREANDGFDGSWVAHPDLVPIAMESFDRVLGDRPNQKDRLREDVDVKAEDLIAIDSLDARPTYAGLVNAVQVGIRYIEAWLRGLGAVAIFNLMEDAATAEISRSQIWQWINAGVVLDNGEKVTAELARKVAAEELADIRAEIGEEAFAAGNWQQAHDLLLKVALDEDYADFLTLPAYEQLKG	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSRNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANILLTTIGGPKELTAFLHNMRDHVTRLDRWEPELNEAIPHDERDTTMPAPVATTLRTLLTVELLTLASRPRLIDWMEADKVAGPILRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	189.16	gnl|BL_ORD_ID|1475|hsp_num:0	1614			306	492	ampicillin
BGC0000229.1|Grincamycin_3 # 2407 # 2685 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728	BGC0000229.1|Grincamycin_3 	2407	2685	-	Loose	450	23.483	ECV-1	41.94	3006883	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ECV beta-lactamase	GTGACGGCCGACGCACGGCGCGTGGAGATCGAGTACTGCACCCGGTGCCGTTGGCTGCCCCGGGCGGCCTGGCTGGCGCAGGAGCTGCTGACCACCTTCGAGCAGGAACTGACCGAGCTGGCGCTCAAGCCCGGGACCGGCGGGGTGTTCGTGGTCCGGGTCGGGGACGAGGTCGTCTGGGACCGGCGGGAGCAGGGCTTCCCGGAGCCGACGGCGGTGAAGCAGGCCGTACGCGACCGAGTGGCCCCGGGGAAACCCCTGGGCCACTCGGAGAGGTGA	MTADARRVEIEYCTRCRWLPRAAWLAQELLTTFEQELTELALKPGTGGVFVVRVGDEVVWDRREQGFPEPTAVKQAVRDRVAPGKPLGHSER	MYYSLLISAFLLSISACGGKSEKLQEHLVAEQTSTFTEKEVYSSDKLIIKQVSPHTYVHVSFLDTDTFGKVACNGMIVISDGEAVVFDTPSTSNETSELLSFLEEEKLQVNAVVATHFHLDCLGGLEAFHARNIPSYAFKNTLSLASQHDFPQPQKGFSDELTLKVGTKAVFVHYFGEGHTQDNVIGYFPDDQVLFGGCLIKANGAGKGNLEDANVEAWPVTVNKISTAYPNLRLVIPGHGNWGDKTLLHYTETLFK	35.80	gnl|BL_ORD_ID|3528|hsp_num:0	4597			480	573	
BGC0000229.1|Grincamycin_4 # 2682 # 3704 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0000229.1|Grincamycin_4 	2682	3704	-	Loose	1650	26.1794	Streptococcus agalactiae mprF	35.56	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGTCACCTGTCCGGGGCGCGGGCGCCGCCCGGGGAGCGGCTGTCACGCTCGGTTACTATGCTTCTTTCGTGCCGGAACCGGCCGGTAAGGGGCGCACGATGACCGACGGACTGAGACACGTGACCACCACGCGTTACGTCATGCCCCTGCACTCCGGAGGGTCCGTCCCCGGCGTCTTCGAAGCCGACGACCTGGGCACCTACGTCGTCAAGTTCACCGGCTCCGCGCAGGGCCGCAAGGCGCTGGTCGCCGAGGTGATCGTCGGCGAGCTGGCGCGGGCACTCGGGCTGCGGTTCCCCGAACTGGTGCTGGTGCACTTCGACCCGGCGATCGCCGACGCCGAACCCCACCAGGAGGTGCGCGACCTGCACGCCTCCAGCGCAGGGGTCAACCTCGGCATGGACCATCTGCCGGGCGCCCGCGACCTCACCCCCGAGGCGGCCGAGACGTTCACCGTCGATCCGCTGGAGGCCGGGCGGATCGTCTGGCTCGACGCGCTCACCGCGAACGTCGACCGCACCGTGCACAGCTCCAACCTGCTGCTGTGGCCCACCCTCGGGGTCGCCCCGCCCCGGCTGTGGCTGATCGACCACGGCGCCGCGCTCGTCTTCCACCACCGCTGGGACGCCGGCGACCCCACGAAGGCGTACGACTTCCGCCACCACGCCCTCGGCCGGTACGGACCCGACGTGCGCGCCGCCGACGCGGAGCTGGCGCCCCGGGTGACGGAGGAACTGCTGCGGTCGATCGTGGACGAGGTGCCCGACGCCTGGCTGGACGGTGAGCCGGGGTTCGGCTCGCCCGAGGCGGTCCGCGCGGCGTACGTGGACCACTTGCACGCGCGGGCACGGGCGTCCGGCGCATGGCTGCCCCTCGACTTCCCCACGGCCGACCAGATCGCCGCGGAGAACGCCCTCCGCGCGGCACGGACGCAACAGGGCCGGCCGGCCTGGCTCAAGCAGGTGCCGGACCTGCACGGCCGGCCGGCGGTGGAACAGGACGGGACGGTGCACCTGCGGTGA	MSPVRGAGAARGAAVTLGYYASFVPEPAGKGRTMTDGLRHVTTTRYVMPLHSGGSVPGVFEADDLGTYVVKFTGSAQGRKALVAEVIVGELARALGLRFPELVLVHFDPAIADAEPHQEVRDLHASSAGVNLGMDHLPGARDLTPEAAETFTVDPLEAGRIVWLDALTANVDRTVHSSNLLLWPTLGVAPPRLWLIDHGAALVFHHRWDAGDPTKAYDFRHHALGRYGPDVRAADAELAPRVTEELLRSIVDEVPDAWLDGEPGFGSPEAVRAAYVDHLHARARASGAWLPLDFPTADQIAAENALRAARTQQGRPAWLKQVPDLHGRPAVEQDGTVHLR	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	40.14	gnl|BL_ORD_ID|2059|hsp_num:0	2283			1932	2058	defensin
BGC0000229.1|Grincamycin_5 # 3722 # 4840 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.721	BGC0000229.1|Grincamycin_5 	3722	4840	-	Loose	275	26.5646	AAC(6')-Iz	32.65	3002570	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTCCACACACCCCCTGGACCGCGTCCGGGACATACTGGTCCGTCCGTTCTCCGTCGGCGGCCTCAACCTGCCCAACCGCGTCGTGATGGCGCCCATGACCCGGGAGTTCTCCCCCGGCGGAGTCCCCGGCGACGACGTGGCGCGCTACTACGCCCGGCGGGCCGCGGGCGGCGTCGGCCTGCTCGTCACCGAGGGCACCTACATCGACCACGCCTCGGCCGGCAACAGCGCCCGGGTGCCGCACTTCTACGGCGACGAGGCGCTGGCCGGCTGGTCCGCGGTCGCCGAGGCGGTCCACCGGGAAGGCGGCAGGATCATGCCGCAGCTGTGGCACGTCGGCATGGACCGCACCGCGGGCAACCCGCCCGTGCCGGACGCCCCGAGGATCGGCCCCTCCGGCATCGCCCCCGACGGTTCGCACTCGGGCCGGGAGATGACCCAGGCCGACATCGACAACGTCGTGGCGGCCTACGCGTCCGCCGCCGCGTCGGCCGAGGCCCTCGGATTCGACGGCGTGGAGATCCACGGCGGCCACGGCTACCTGGTCGACCAGTTCCTGTGGTCCCGCACCAACCGGCGCACCGACCGGTACGGCGGTGACGTCGCCCGGCGCACCCGGTTCGCCGCCGAGATCGTGGCGGCCTGCCGTGCGGCCGTGTCCGACGACTTCCCGATCTCGTTCAGGCTGTCCCAGTGGAAGGTCGACCACTACGGGGCGCGGATCGCCGAGACCCCCCAGGAGCTGGAGACGGTGCTGGGGCTGCTGGCCGAGGCAGGCGCCGACATCTTCCACTGCTCCACCCGGCGCTTCCACGTCCCGGAGTTCGAAGGCTCGGACCTCAACCTCGCGGGCTGGGCGAAGAAGCTCTCCGGCAAGCCCGCCGTCAGCGTGGGCTCGGTGGGCATGAGCAACGAGTTCCTCGACGTGTTCCAGGGCGAGCAGGCGGCCGTCACGGACATCGGGAACCTGCTCGACCGCATGGAGCGCGACGAGTTCGACCTGATCGCGGTGGGCCGCGCACTCCTCGGCGACCCCGAGTGGCTGGCCAAGATCCTTTCCGGCCGCACCGGCGAACTCACGCCCTTCCACGTGAGCCGGATCGGCACCCTCCACTGA	MSTHPLDRVRDILVRPFSVGGLNLPNRVVMAPMTREFSPGGVPGDDVARYYARRAAGGVGLLVTEGTYIDHASAGNSARVPHFYGDEALAGWSAVAEAVHREGGRIMPQLWHVGMDRTAGNPPVPDAPRIGPSGIAPDGSHSGREMTQADIDNVVAAYASAAASAEALGFDGVEIHGGHGYLVDQFLWSRTNRRTDRYGGDVARRTRFAAEIVAACRAAVSDDFPISFRLSQWKVDHYGARIAETPQELETVLGLLAEAGADIFHCSTRRFHVPEFEGSDLNLAGWAKKLSGKPAVSVGSVGMSNEFLDVFQGEQAAVTDIGNLLDRMERDEFDLIAVGRALLGDPEWLAKILSGRTGELTPFHVSRIGTLH	MIASAPTIRQATPADAAAWAQLRLGLWPDADDPLEELTQSLADAEGAVFLACAADGETVGFAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDSRVEDVQAHAAHRACGFEETERVVYFRMPLEPSA	243.14	gnl|BL_ORD_ID|1840|hsp_num:0	1995			72	213	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000229.1|Grincamycin_6 # 5064 # 6581 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.717	BGC0000229.1|Grincamycin_6 	5064	6581	-	Loose	950	214.157	tcr3	37.32	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGCCCGTCCGACCGCAGCGCCCACCCCGCCCGACCGCGCCGGCCTGCCCCGGCTCGGCGTCTTCGGCCTGATGCTGGGCATCTTTCTGGCGACGCTCGACGGCCAGATCGTCAGCACGGCGCTGCCCACCATCGTGGGCGACCTGGGGGGACTCGAGCACTTCTCCTGGTCGGTGACGGCCTACCTGCTCACCATGGCCGCCGCCACCCCGTTGTGGGGCAAACTCGGAGACCTCCACGGCCGCAAGGGCGCCTACAGCAATGCCGTGGTGCTCTTTCTGATCGGCACAGTTCTGTGCGGTCTGGCCCAGAACATGGGTCAGCTCATCGCCTTCCGGGCCGTGCAGGGTCTCGGAGCCGGCGGACTCATGGTGGGCGCGCTCTCGGTGATCGGCGTTCTGGTGCCCCCGGAGGGACGTGGCCGCATCCAGTCGATGGTGGGCGTCATGATGCCCGTCGCCTTCGTCGGCGGCCCGCTCCTCGGCGGACTCGTCACCGAGCACCTGGACTGGCGCTGGACGTTCTACGTCAACGTCCCCGTCGGTCTCGTCGCTCTGCTGGCCGTCGCCAAGGGAGTGCGGCTGCCCGCACAGCGCGTCCCCGGGCACGTCGACTACGTCGGCGCCGCTCTTCTCACCAGCGGTGTCCTGGCCCTCACCCTGCTCGCCGGGTGGGCCGGCACCACGTACCCCTGGCTGTCCTGGCAGATCTCCGCGCTCGCGGCCCTGGTCGTGGTGAGCCTCGCCTGGTTCGTCCGGGTGGAACGGCGCGCCGTCGAACCGATCACCCCGCCCCGGCTGTTCGCCCGGCGGGAGTTCACCCTCGCCCAGGTGCTCAGTCTCCTCGTGGGCGCGATCCTCATCTCCGTCGTCAACTACCTCCCTCAGTACATGCAGTTCGTACAGGGCGCGTCGCCCACCGCCAGTGGCATGCTGATCCTGCCGCTGATGCTCGGCATGCTGTCGGCACAGCTGACCACCGGGCGGCTCATGGACCGCGGCGGGCTGGACCGCGTCGTGCCGCTCACCGGCTCCCTCGCCACCGTCGCCGGCGCGCTGCTGCTGCTCCTGCTCGGCACGGACACCCCCCTCGCCGTGGCCTCGGCCCTCACCCTCGTGGCCGGCGTCGGCATCGGGATGCTGATGCAGAGCACCCTGCTCACCACCATGAACAACGCCGATCCCCGCGACATGGGGGCCGCCACCGGCACCGTCACCCTGGTGCGCACCATCGGCGGCTCCCTCGGCGTCGCCGTCCTCGGCGCCGTGCACAGCAGCCGTACGTCCGGCGTCCTCGCCGGCCGGCTCGGCGGCGACACGGAACAACGGCTGACCATCGGCGGCGAATTGACCCCCGCCGCGTTGGCAGATATGCCCCGGGAGGTGCGCGACGCCGTCGGGCAGGCGGTGAGCAGCGGACTGCACGGCGTGGTGACCGGCGCGGCCCTCCTGGCGGTGTGCGCGTTCGCCAACGGCGTGGTTCATCCGCGCGGCGCCGGCCGCCCGGCCGTCTGA	MTARPTAAPTPPDRAGLPRLGVFGLMLGIFLATLDGQIVSTALPTIVGDLGGLEHFSWSVTAYLLTMAAATPLWGKLGDLHGRKGAYSNAVVLFLIGTVLCGLAQNMGQLIAFRAVQGLGAGGLMVGALSVIGVLVPPEGRGRIQSMVGVMMPVAFVGGPLLGGLVTEHLDWRWTFYVNVPVGLVALLAVAKGVRLPAQRVPGHVDYVGAALLTSGVLALTLLAGWAGTTYPWLSWQISALAALVVVSLAWFVRVERRAVEPITPPRLFARREFTLAQVLSLLVGAILISVVNYLPQYMQFVQGASPTASGMLILPLMLGMLSAQLTTGRLMDRGGLDRVVPLTGSLATVAGALLLLLLGTDTPLAVASALTLVAGVGIGMLMQSTLLTTMNNADPRDMGAATGTVTLVRTIGGSLGVAVLGAVHSSRTSGVLAGRLGGDTEQRLTIGGELTPAALADMPREVRDAVGQAVSSGLHGVVTGAALLAVCAFANGVVHPRGAGRPAV	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	98.63	gnl|BL_ORD_ID|592|hsp_num:0	652			135	1371	tetracycline
BGC0000229.1|Grincamycin_7 # 6612 # 7211 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.702	BGC0000229.1|Grincamycin_7 	6612	7211	-	Loose	920	25.7942	OpmD	28.3	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCTGGCACCAGTGACGGCCCCCTGCGGACCGCAGTGATCATCGGCAGTACCCGGGACGGCCGCTTCGGCCCCGTCGTGACGGACTGGATCACGGGCCACATCGCCGAGCGTGAGGACATGACGGCCGACGTGATCGACCTTGTGGCCACGCCGCTCCCCACCGTTTTCCCGGCCTTCGGGCAGCCGCCCTCCGCCGAGGTGGTGGTGCAGCTGGGCGAGGTGTCGCCGAGGCTGGCCGCGGCCGACGCCTTCGTGATCGTCACTCCGGAGTACAACCACAGCTTCCCGGCGGCACTGAAGAACGCCATCGACTGGCACAACGAGCAGTGGCACGCCAAGCCGGTGGGATTCGTCTCCTACGGCGGCCTGTCCGGAGGCCTGCGCGCCGTCGAGCAGCTCCGCGTCGTCCTCGCCGAACTGCACGCCGTGACCATCCGCAACACGGTCAGCTTCCACAACTACGGCGAGGTCTTCGGGGGCGACGGGAAGCCGGCGGACCCCGGCTGTGATGTCGCCGCCAAGGCGATGCTCGACCAGCTCACCTGGTGGGGCCACGCGCTCCGGGACGCCAAGGCCGTCCGCCCGTACGCCGTCTGA	MAGTSDGPLRTAVIIGSTRDGRFGPVVTDWITGHIAEREDMTADVIDLVATPLPTVFPAFGQPPSAEVVVQLGEVSPRLAAADAFVIVTPEYNHSFPAALKNAIDWHNEQWHAKPVGFVSYGGLSGGLRAVEQLRVVLAELHAVTIRNTVSFHNYGEVFGGDGKPADPGCDVAAKAMLDQLTWWGHALRDAKAVRPYAV	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	40.86	gnl|BL_ORD_ID|450|hsp_num:0	442			1233	1383	acriflavine; tetracycline; norfloxacin
BGC0000229.1|Grincamycin_8 # 7344 # 8081 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0000229.1|Grincamycin_8 	7344	8081	+	Loose	400	44.669	tetR	25.87	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCTCCCAGGAGCGACAGGCACAGGCCCACGACAAGGACCACGTCTCCGTGTGGGAGCGCCTCGAACGGCCCGCACCCGCGCCCCGCACCACGCTCACGCCCCGGCGTATCGCCAAGGCCGCGGTGGCCGTCGCCGACGCGGAGGGACTGGACGCGGTCACGATGCGGCGCCTGGCCACCGAGCTGGGCGTCGCCCCCATGGCCGCGTACCGCTACGTGACCGGCAAGGACGAGCTCATCGAGCTCATGGTCGACTTCGTCTACGCGGAGATGGATCTGCCGGGCGAGACCGACAACTGGCGCACGACCATGCACACGCTCGCCCTGCGCATCAGGGAGGTCCTCCTCCGCCACTCCTGGGTCACCCGGGCCACCTGGTGCGCCCCGACGCCGAACCAACTGGCCGTTCCGGAGGCCGCCCTGGCCGCGCTCGACGGCCTCGGGCTGGACGCCGACACGGCGATGGTGGTCTACAGCACGGTCACGTCGTACGTGCACGGCGCGGTCAACGCCGAGGTCGGCGTGACCCAGTTGCTGCGCGTGCGAGGGTGGTCCAGCCGGGAGGAGGCCAGGTCGGGACTCGCCTCTCAGATGGCCTGGCTTCTGAGCACGGGCCGTTTCCCGATGTACGAGCGTTACATCGGCGAGGCCGGACGTAAGGACGACCTGCAGTGGCAGTTCGAAACCGGTCTCGAGTGCGTTCTGGACGGTATCTCCGAACACCTCAAGATCTGA	MPSQERQAQAHDKDHVSVWERLERPAPAPRTTLTPRRIAKAAVAVADAEGLDAVTMRRLATELGVAPMAAYRYVTGKDELIELMVDFVYAEMDLPGETDNWRTTMHTLALRIREVLLRHSWVTRATWCAPTPNQLAVPEAALAALDGLGLDADTAMVVYSTVTSYVHGAVNAEVGVTQLLRVRGWSSREEARSGLASQMAWLLSTGRFPMYERYIGEAGRKDDLQWQFETGLECVLDGISEHLKI	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	117.79	gnl|BL_ORD_ID|442|hsp_num:0	276			12	438	tetracycline
BGC0000229.1|Grincamycin_9 # 8228 # 9070 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000229.1|Grincamycin_9 	8228	9070	+	Loose	700	26.9498	oleD	42.55	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGACATACCGATCCACGGACATCATCAAGAACGAACGGGCCACGACACAGCCGGCGGAGTGCGAGGGGGCGGCCTGCCGGCACGGCGCGGCGGACCGCGCCCGGGATCTCGCCGCACGGGGCGGCCGGCTCTGCCCGCCCTGTGCGTTACGGCTCACCCACGACCTGCGACGGCTGCCCCGTCTCCATGAGGAGTGCGGCGGTCTGCTCACCGGAACCGACCGGCCCCGCGACCGCACGTCCGGTGGCCCGCTGCCCGGACTGCCCTTCAACACGGCCGCGGCCGAGGCCCGTTCCGTCATCGTCGCCACCCTGAGGTCCTGGGCCGCGCTGGTGATCGACGAACGGCGGGTGAGCGCTCCGCCGGACACCGTCGCGCACATGGCCGGCTTCCTGCTCCGGCACATCGACTGGCTCGTCGCGCACCCGGCCGTGGCCGACCTGTCGTCCGAGGTCACAGGGTGCGTCCGGCGGGCGCGACGGGTGATCGACCCCGCCCCGAGACGCCGGCTGCCGGTCGGCGCCTGCGTGGTTCCGGGCTGCGGAGGAACGCTGAGGGCGGAGGTGCGGTCCGGCTCCGGCGACACGGTCGAGGTGGGCTGCGACAGCGAGCCGGCGCACCGCTGGTCCGGGCAGGAATGGCTCCGCCGCGGCAGCCGCCCCGCGCGGCGGGAGCAGCCGGTGCGCTGGATGACGGCACGTGACATCGCCCGTCTGTGGGGCCTCGCCCCGGGCAGCGTCTACCGCCGTGCGAGCGAGGACCGGTGGCGCCGGCAGAGTGTGCGCGGGCGCGCGTACTACCACGGGGAGGATGTCCTCACCTCGCTCGGAACACACTCGTAA	MTYRSTDIIKNERATTQPAECEGAACRHGAADRARDLAARGGRLCPPCALRLTHDLRRLPRLHEECGGLLTGTDRPRDRTSGGPLPGLPFNTAAAEARSVIVATLRSWAALVIDERRVSAPPDTVAHMAGFLLRHIDWLVAHPAVADLSSEVTGCVRRARRVIDPAPRRRLPVGACVVPGCGGTLRAEVRSGSGDTVEVGCDSEPAHRWSGQEWLRRGSRPARREQPVRWMTARDIARLWGLAPGSVYRRASEDRWRRQSVRGRAYYHGEDVLTSLGTHS	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	67.47	gnl|BL_ORD_ID|1253|hsp_num:0	1367			348	489	erythromycin; tylosin
BGC0000229.1|Grincamycin_10 # 9087 # 9257 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.515	BGC0000229.1|Grincamycin_10 	9087	9257	-	Loose	450	23.483	imiS	41.94	3003095	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGTCAATGCAAATTTTCGAACCCTGCAACAAGCTTGCGTCAGAGAATCGTCAAATAGATTTCCGCAGGCAACTTCATGCACTGGGCAGGCGCGTGCAGAGAAAAAAGAAAGAGGCTCTGCCGGATCGTTCCCATTCCGGCAGAGCCTCGTTCTTCTGCTGGTTGCTCTGA	MSMQIFEPCNKLASENRQIDFRRQLHALGRRVQRKKKEALPDRSHSGRASFFCWLL	MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVISTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYLGPAHSPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAASQS	21.96	gnl|BL_ORD_ID|249|hsp_num:0	278			213	306	
BGC0000229.1|Grincamycin_11 # 9396 # 10883 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.716	BGC0000229.1|Grincamycin_11 	9396	10883	+	Loose	600	331.643	Streptomyces venezuelae rox	44.78	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACGCTTCCGTCATCGTCGCCGGCGCGGGTCCCACCGGACTCATGCTCGCCGGGGAGCTACGGCTCGCGGGGGTCGGCGTCATCGTGCTGGACCGGCTCACCGAGCGCACCGGCGAGTCCCGTGGACTGGGCTTCACCACTCGCACCATGGAGGTCTTCGACCAGCGCGGACTGCTCCACCGCTTCGGGGACATGGGCACCAGCAACGCCGGGCACTTCGGCGGCCTGCCGGTCGACTTCGGTGTCCTCGACAGCATTCACGAGGCCGCCAAGACCGTGCCTCAGTCGGACACCGAGACGATGCTGGAGAGCTGGGTCCGCGAGCTCGGCGCCGACGTCCGGCGCGGCCACGAACTGGTCTCCCTGCGGGACCACGGGGACCACGTCGAGGTCGAAGTGCGCGGTCCCGACGGTGAGGAGACCCGGCTGACCGCGCCCTTCCTCGTCGGGTGCGACGGCGGACGCAGCACCGTCCGCAAGGCCGCCGGATTCGACTTCCCGGGCACCGCGGCGACGCTGGAGATGTACCTCGCGGACATCAAGGGCGTGGATCTGAAGCCGAGGCTGATCGGCGAGACCTTCCCCGGCGGCATGGTGATGTGCGGCCCGCTCGGCAACCGGGGCGTCACCCGCATCATCGTCTGCGAACGCGGCACCCGGCCCCGCCGACGCACCGAACCGCCCTCCTACCCGGAGGTCGCGGCCGCCTGGCAGCGGATCACCGGCATCGACATCTCGCACGCCGAACACGAGTGGGTGAGCGCCTTCGGCGACGCCACCCGCCTCGTCACCGAGTACCGCCGAGGTCGCGTGCTGCTCGCCGGGGACGCGGCGCACATCCATCTGCCGGCGGGCGGCCAGGGGATGAACACCGGTATCCAGGACGCCGTGAACCTGGGCTGGAAACTGGCCGCCGTCGTCCGCGGCACCGCCCCGGAGGCGCTGGTGGACACCTACCACGCCGAGCGGTACCCGGTCGGCGAACGGCTGATGACGAACACGAAGGCCCAGGGACTGCTCTTCCTCACCGGCGAGGAGATGCAGCCGCTGCGTGACGTCCTGGCGGAGCTCATCCGCTACGAGGAGGTCAGCCGCCACCTCGCCGGCATGGTGAGCGGCCTGGAGATCCGCTACGACGTCGGTCCCGGCCCGCACCCTCTGCTGGGGCTGCGCATGCCGCATCTGGAACTCGTGGGCGAGCGGCGCAAGACCAGCAGCACCGAACTGCTCAAGCCGGCCCGGGGCGTGCTGCTCGACCTGGAGGACAACGCCGTCCTCCGCGAACGCGCGGCCGGCTGGTCGGACCGCGTCGACATCGTCACGGCGGAGCCCCACGACGTCCGGCCCGGCACTCCCCTCGCGGACACGGCGGCGGTCCTGGTGCGGCCCGACGGACACGTGGCCTGGGCGGCACCGGGCAGCCATCACGACCTGCCCATGGCACTGGAGCGCTGGTTCGGTCCGTCCCGGATCCAGCAGTCCTGA	MDASVIVAGAGPTGLMLAGELRLAGVGVIVLDRLTERTGESRGLGFTTRTMEVFDQRGLLHRFGDMGTSNAGHFGGLPVDFGVLDSIHEAAKTVPQSDTETMLESWVRELGADVRRGHELVSLRDHGDHVEVEVRGPDGEETRLTAPFLVGCDGGRSTVRKAAGFDFPGTAATLEMYLADIKGVDLKPRLIGETFPGGMVMCGPLGNRGVTRIIVCERGTRPRRRTEPPSYPEVAAAWQRITGIDISHAEHEWVSAFGDATRLVTEYRRGRVLLAGDAAHIHLPAGGQGMNTGIQDAVNLGWKLAAVVRGTAPEALVDTYHAERYPVGERLMTNTKAQGLLFLTGEEMQPLRDVLAELIRYEEVSRHLAGMVSGLEIRYDVGPGPHPLLGLRMPHLELVGERRKTSSTELLKPARGVLLDLEDNAVLRERAAGWSDRVDIVTAEPHDVRPGTPLADTAAVLVRPDGHVAWAAPGSHHDLPMALERWFGPSRIQQS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.99	gnl|BL_ORD_ID|4833|hsp_num:0	5820			9	1419	rifampin; rifaximin; rifapentine
BGC0000229.1|Grincamycin_13 # 11220 # 12500 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000229.1|Grincamycin_13 	11220	12500	+	Loose	750	185.267	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.09	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCGGCGCGTACCCCCGGCGGGTGGTGATCACCGGCATCGGGGTCACCGCCCCGGGCGGCGTGGGCGTCAAGAGCTTCTGGAACACCCTGTCCGGCGGGCACACGGCGACCCGTCGCATCACCTTCTTCGATCCCTCCCCCTTCCGCTCCCAGGTCGCCGCGGAGGTCGACTTCGACGCGGAGCTGCTGGGGCTGAGCGCCCAGGAGATCCGGCGGATGGACCGCGCCGCCCAGTTCGCGGTGGTCACGGCCCGGGACGCGGTTGCCGACAGCGGCCTGGAGTTCACCGCCCTGGACCCGCACCGCACCGGCGTCACCATCGGCAGCGCGGTCGGCGCCACCATGGGACTGGACCAGGAGTACCGCACGGTCAGCGACAGCGGCCGGCTCGATCTGGTCGACCACACCTATGCGGTCCCGCACCTGTACAACCACCTCGTGCCCAGTTCCTTCGCCGCGGAGGTCGCCTGGGCGGTGGGCGCCGAGGGACCGGCCACCGTGGTGTCCACCGGCTGCACGTCCGGGCTGGACGCCGTGGGCTACGCCGCCGACCTGATCCGGGAGGGATCGGCCGACGTCATGGTGGCCGGTGCCACCGACGCGCCCATCTCCCCCATCACGGTGGCCTGTTTCGACGCGATCAAGGCGACGACCCCGCGCAACGACGACCCCGAGCACGCCTCGCGCCCGTTCGACGGCACCCGCAACGGCTTCGTGCTGGGTGAGGGTGCCGCCGTCTTCGTCCTGGAGGAACTCGGCAGCGCCCGGCGGCGCGGTGCCCATGTCTACGCGGAGATCGCCGGTTACGCGACGCGCAGCAACGCCTTCCACATGACGGGCCTGCGTCCGGACGGCCGGGAGATGGCCGAGGCCATCCGGGTCGCCCTGGACGAGGCGCGCCTGGATCCCGAGGCCGTCGACTACGTCAACGCACACGGCTCGGGCACCAAGCAGAACGACCGTCACGAGACCGCCGCGTTCAAGCGCAGCCTCGGCGAGCACGCCTACGCCGTGCCGGTCAGCTCCATCAAGTCGATGGTGGGCCACTCGCTGGGAGCGATCGGGGCCATCGAGATCGCGGCGAGCACGCTGGCCATGGAGCACGGCGTCGTGCCGCCCACCGCCAACCTGCACACCCCGGACCCCGAGTGCGACCTCGACTACGTCCCGGTCACCGCACGGGAGTGGCCCACCGACGCCGTGCTGTCGGTGGGCAGCGGTTTCGGCGGTTTCCAGAGCGCCATGGTGCTCGCCCGCCCGGATCGGAGGAACGCATGA	MSGAYPRRVVITGIGVTAPGGVGVKSFWNTLSGGHTATRRITFFDPSPFRSQVAAEVDFDAELLGLSAQEIRRMDRAAQFAVVTARDAVADSGLEFTALDPHRTGVTIGSAVGATMGLDQEYRTVSDSGRLDLVDHTYAVPHLYNHLVPSSFAAEVAWAVGAEGPATVVSTGCTSGLDAVGYAADLIREGSADVMVAGATDAPISPITVACFDAIKATTPRNDDPEHASRPFDGTRNGFVLGEGAAVFVLEELGSARRRGAHVYAEIAGYATRSNAFHMTGLRPDGREMAEAIRVALDEARLDPEAVDYVNAHGSGTKQNDRHETAAFKRSLGEHAYAVPVSSIKSMVGHSLGAIGAIEIAASTLAMEHGVVPPTANLHTPDPECDLDYVPVTAREWPTDAVLSVGSGFGGFQSAMVLARPDRRNA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|1968|hsp_num:0	1943			306	1245	isoniazid
BGC0000229.1|Grincamycin_14 # 12497 # 13717 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.725	BGC0000229.1|Grincamycin_14 	12497	13717	+	Loose	750	98.9821	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	31.97	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGCGACCGGCGTGCGAGCCGCCGTCACCGGACTGGGTGTCGTCGCACCCAACGGACTGGGCACGGAGACCTACTGGACCGCGACCCGCAAGGGGATCAGCGGCATCGGACGCATCACGCGTTTCGTGCCCGACCAGTACCCCGCCCAACTGGCGGGTGAGATAGACGGGTTCGACGCGGCCGAGCATCTGCCGGGACGGCTGCTGCCGCAGACGGACCGGATGACCCAGCTCGCGCTGGTGGCCGCGGACTGGGCTTTCCAGGACGCCGCGGTGCGGCCGGAGGACCTTCCCGGATTCGAGATGGGGGTCATCACCGCCAGTTCCTCCGGAGGCTTCGAGTTCGGCCAGCGGGAGCTCCAGGCGTTGTGGAGCAAGGGCAGCAGGTACGTCAGCGCGTACCAGTCCTTCGCCTGGTTCTACGCCGTCAACAGCGGTCAGATATCCATCCGCAACGGCATGCGAGGGCCCAGCGGTGTGGTCGTCAGCGACCAGGCCGGCGGGCTCGACGCGATCGCCCAGGCACGGCGGCAGCTGCGCAAGGGCACACGGCTGGTGATGGCGGGCGCCGTCGACGCGTCGATCTGCCCCTGGGGCTGGGTCGCCCAGATGGCGAGCAACCGGCTGAGCGTCGGCCGTGACCCCGAACGTGCCTACCTTCCTTTCGACGACGCGGCAGCGGGGCACGTGCCCGGTGAGGGCGGGGCCCTGCTCGTCATGGAGGATCTGGAGCAGGCCCGGGCCCGGGGCGCTCGGATCTACGGTGAGGTCGCCGGATACGGCGCCACGCTGGACCCTCGGCCGGGCAGCGGGCGGCCCCCCGGCCTGCGCAAGGCCGTCGAACTCGCCCTGGCCGACGCCGGAGCGTCGCCCGGTGACATCGACGTGGTGTTCGCCGACGCGGCCGCCCTGCCCGACCTGGACCGCATCGAGACCGAGGCGATCACGGCGGTGTTCGGCGCGCGGGCCGTGCCCGTGACGGCGCCCAAGACGATGACCGGGCGGCTGTATTCCGGGGCGGCGCCGCTGGATCTGGCCGCGGCGTTCCTCGCCATGCGGGACGAGGTGATACCGCCGTCCGTCGGCGTCACCCCCTCTCCCGGTCACGACCTGGACCTGGTCGTCGACCGGGAACGGCCGGCCCCGGTGCGCTCCGCCCTGGTGCTCGCCCGGGGGCACGGCGGCTTCAACTCCGCGGCCGTGGTGCGCGCGGTCTGA	MSATGVRAAVTGLGVVAPNGLGTETYWTATRKGISGIGRITRFVPDQYPAQLAGEIDGFDAAEHLPGRLLPQTDRMTQLALVAADWAFQDAAVRPEDLPGFEMGVITASSSGGFEFGQRELQALWSKGSRYVSAYQSFAWFYAVNSGQISIRNGMRGPSGVVVSDQAGGLDAIAQARRQLRKGTRLVMAGAVDASICPWGWVAQMASNRLSVGRDPERAYLPFDDAAAGHVPGEGGALLVMEDLEQARARGARIYGEVAGYGATLDPRPGSGRPPGLRKAVELALADAGASPGDIDVVFADAAALPDLDRIETEAITAVFGARAVPVTAPKTMTGRLYSGAAPLDLAAAFLAMRDEVIPPSVGVTPSPGHDLDLVVDRERPAPVRSALVLARGHGGFNSAAVVRAV	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	97.60	gnl|BL_ORD_ID|1968|hsp_num:0	1943			87	1230	isoniazid
BGC0000229.1|Grincamycin_15 # 13794 # 14063 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0000229.1|Grincamycin_15 	13794	14063	+	Loose	275	25.0238	AAC(6')-Ib-SK	32.81	3002593	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCCCGCCCATGAGTTCACCCTTGAGGACCTCAAGCGCATCCTGCGCGAGGGGGCCGGCGCGGACGAAGGCGTCGATCTCGACGGCGACATCCTCGACACCGATTTCGGTTCGCTGGGCTACGAGTCCCTGGCGCTGCTGGAGACCGGCGGCAGGATCGAGCGTGAGTTCGGCATCACCCTGGACGACGAGACGCTGACCGACGCGGCGACGCCGCGATCGCTGCTCGAGGCCGTCAACGCCCTGCTGGTACCGGCCGAGGTCGGCTGA	MPAHEFTLEDLKRILREGAGADEGVDLDGDILDTDFGSLGYESLALLETGGRIEREFGITLDDETLTDAATPRSLLEAVNALLVPAEVG	MRAHRSCCIRRRGLGHNAGVELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYEEMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERGHHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV	50.57	gnl|BL_ORD_ID|945|hsp_num:0	1024			24	216	amikacin; kanamycin A; tobramycin
BGC0000229.1|Grincamycin_16 # 14192 # 14977 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.692	BGC0000229.1|Grincamycin_16 	14192	14977	+	Loose	750	33.4982	mdtH	24.17	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACACAGCAGAAGCCGAAGGTGGCCCTCGTCACGGGCGCGACCAGCGGCATCGGCCTGGCGGTGACCAGGCTGCTGGCCCGCGACGGCCACCGGGTGTTCCTCTGTGCCCGCACCGAGACCGGCGTGACCCGCACGGTCAAGGAACTGCTCGACGAGGGGCTGGACGTGGACGGCGCCCCGTGCGACGTACGCTCCGGGACCGACGTCAAGCGCCTCGTGACGCGGGCAGTTGACCGCTTCGGCACCATCGACGTACTCGTCAACAACGCCGGCAGGTCCGGTGGCGGGGTCACCGCCGAACTCCCCGACGACCTCTGGTCCGACGTGATCGAGACCAACCTCAACAGCGTCTTCCGGGTGACGCGCGAGGTGCTCACCACCGGCGGTATGCGCGACAAGGACCGTGGCCGGATCATCAACGTCGCCTCCACCGCGGGCAAGCAGGGCGTGGTGCTCGGCGCCCCCTACTCGGCCTCCAAGCACGGTGTCGTCGGCTTCACCAAGGCGCTCGGCAACGAGCTCGCGCCCACCGGCATCACCGTGAACGCCGTCTGCCCCGGCTACGTCGAGACGCCGATGGCACAACGGGTGCGCCAGGGCTACGCGGCCGCCTACAACACCTCCGAGGACGCGATCCTCGAGAAGTTCCAGGCGAAGATCCCGCTGGGCCGCTACTCGACCCCCGAGGAAGTCGCGGGCCTGGTCGGCTATCTGGCCTCCGACACCGCCGCCTCCATCACCTCGCAGGCGCTGAACGTCTGCGGCGGTCTGGGCAACTTTTGA	MTQQKPKVALVTGATSGIGLAVTRLLARDGHRVFLCARTETGVTRTVKELLDEGLDVDGAPCDVRSGTDVKRLVTRAVDRFGTIDVLVNNAGRSGGGVTAELPDDLWSDVIETNLNSVFRVTREVLTTGGMRDKDRGRIINVASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQRVRQGYAAAYNTSEDAILEKFQAKIPLGRYSTPEEVAGLVGYLASDTAASITSQALNVCGGLGNF	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	64.93	gnl|BL_ORD_ID|342|hsp_num:0	375			129	456	enoxacin; norfloxacin
BGC0000229.1|Grincamycin_17 # 14998 # 15933 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.703	BGC0000229.1|Grincamycin_17 	14998	15933	+	Loose	1500	28.1054	kdpD	40.0	3004047	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGACGACCCGTCAGGTCGAGCACGAGATCACGGTCGGGGCCCCGGCAGCCGCCGTCTACCGGCTGATCGCCGACGTGGAGAACTGGCCGCGGATCTTCCCTCCCACCATCTACGTCGACCATGTCGAGCGCTCGGCGGGCGAGGAGCGCATACGGATCTGGGCGACCGCCAACGGCGAGGCGAAGAACTGGACCTCGCGCCGCACGCTGGACCCGGACGGTCTGCGGATCACCTTCCGGCAGGAGGTCTCGGCCCCGCCGGTGGCCGCCATGGGCGGCGCCTGGGTCATCGAGCCGCTGTCCGACGGCTCGGCCCGGATCCGGCTGCTGCACGACTACCGCGCCGTGGACGACGACCCCGCCGGCCTGCGCTGGATCGACGAGGCCGTCGACCGCAACTCCCGTGCCGAGCTGGCCGCGCTGAAGACCAACGTGGAACTGGCCCACGCCGCGGAGGACGTCACGTTCTCCTTCGAGGACACCGTGCAGATCGCCGGCTCGTCCAAGGACGCCTTCGACTTCGTCGACGAGGCGGGTCTGTGGGCGGAGCGGCTGCCCCACGTGGCCTCGGTCCGCTTCACGGAGCACTCCCCCGGGCTGCAGACCCTGGAGATGGACACCCTGGCCAAGGACGGCTCCACGCACACCACGAAGTCGTACCGGGTGACGTTCCCGCACCACAGGATCGCGTACAAGCAGGTCACTCTGCCCGCGTTGATGACCCTGCACACCGGCCTGTGGACGTTCACGGAGAACGGGAGCGGGGTCGCCGCGACCTCGCAGCACACCGTCACCCTCAACACGGAGAACATCGCTCGGGTCCTCGGACCCGACGCGACCGTGGCCGACGCCCGCGCGTACGTCCAGGGCGCGCTGAGCACCAACAGCCGGGCGACCCTCGGCCATGCCAAGGACCACGCCGAGAAGCGGCGCTGA	MTTRQVEHEITVGAPAAAVYRLIADVENWPRIFPPTIYVDHVERSAGEERIRIWATANGEAKNWTSRRTLDPDGLRITFRQEVSAPPVAAMGGAWVIEPLSDGSARIRLLHDYRAVDDDPAGLRWIDEAVDRNSRAELAALKTNVELAHAAEDVTFSFEDTVQIAGSSKDAFDFVDEAGLWAERLPHVASVRFTEHSPGLQTLEMDTLAKDGSTHTTKSYRVTFPHHRIAYKQVTLPALMTLHTGLWTFTENGSGVAATSQHTVTLNTENIARVLGPDATVADARAYVQGALSTNSRATLGHAKDHAEKRR	MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI	35.14	gnl|BL_ORD_ID|4924|hsp_num:0	5918			168	285	kanamycin A
BGC0000229.1|Grincamycin_18 # 15935 # 17923 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=13bp;gc_cont=0.732	BGC0000229.1|Grincamycin_18 	15935	17923	+	Loose	600	234.958	Streptomyces venezuelae rox	41.69	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCGCGCCGGACACGGATGTGGTCGTCGTGGGGGCCGGGCCGACCGGGCTGATGCTCGCCGGTGACCTGCGGGCCGGCGGGGCGCGGGTGACCGTTCTGGAACGGCTGGAGCGGCCCACGACCGAGTCCCGGGCGTCCGTCCTGCACGCGCGCACCATGGAACTGCTGGCCGAACGGGGCCTGCTGGAACGGTTCGGGCCGCTGCCCGAGGCGGGCCCCGGTCACTTCGGCGGCATCCCTCTCGACCTGAGCGAGGCCGGGAACAGTCCGTACGCCGGACAGTGGAAGGCGCCTCAGACGCATGTCGAAGCCGTCCTCGCCGCATGGGCGAGGGAACTCGGCGTCGAGGTGCGGCGGGGACTCACGGTGACCGGTCTGGCCCAGCGCGCCGACCGGGTGCGTGTCGTCGCCGTGGCACCGGACGGGCGGCGGCTGCGGCTGGACGCCGCCTATGTCATCGGCTGCGACGGCGAGGACAGCACCGTTCGGCGGCTGGGGAACTTCGCGTTCCCGGGGGTCGACTCCGGCAAGGAGCTCTTGCGCGCCGATCTGGCCGGCATCGAACTGCGGGAGCGGCGTTTCGAACGTCATCCCCGGGGCGTGGCCAACGCCCGCCGCGGCCCGGACGGCGTCACCCGCATCATGGTGCACGCCTTCGACCGGACCCCCGGGCCGTCCGGTACCCCCGCCTTCGCCGACGTCTGCGCGGTGTGGGCGCACGTCACCGGCGAGGACATCAGCGCCGCCCGGCCTGTCTGGCTCAACGCCTTCGGCAACGCGCGCCGGCAGGCGGACCGGTACCGCGACGGCCGGGTGTTCCTCGCGGGGGACGCGGCACACGTCCAGCTGCCCGTGGGGGGCCAGGCGCTCAATCTCGGCCTGCAGGACGCCATGGATCTCGGCCCGAAGCTCGCCGCCCGGCTGGCCGGCCGGGCCGGCGACGAGGTGCTGGACAGCTACGGCCTGGTCCGGCGAGCGGTGGGCGCTCGGGTCCTCACCAACATCGAGGCGCAGGCCCAGCTGTTGTTCGGCGGGCCCGAGGTGGACCCGCTGCGGGAGGTGTTCCGCGAGCTGCTGGAGCTCCCCGCGGCCCGCCGCCATCTGGGCGCCATGGTCGGCGGGCTCGACGGCGGCCGCCCCGCGCGGGCCGGCGCCGGCGGGCCGGCCGTGTCCGTGGCCCCCGCTCCGCTCCGTCAGGACATCACGCACAGGAGGATCACGATGGGCAAGCTTTCCGGCAAGACCGCGCTCGTCTCCGGCTCCAGCCGGGGTATCGGACGGGCCACGGCCCTCAGGCTCGCCCGCGACGGAGCGCTGGTCGCGGTGCACTGCTCCAGCAACCGGGCGGCCGCCGAGGAGACGGTCGCCGCCGTGGAGAAGGACGGCGGTCGCGCGTTCTCCGTGGTGGCCGAACTCGGGGTGCCCGGCGATGTGCACGAGCTGTTCCTCGCTCTCGAAAGGGAGCTGAAGGAGCGCACGGGGACGACCACGCTCGACATCCTGGTGAACAACGCCGGGGTGATGGGCGGGGTGGACCCCGAGGAACTGACCCCCGAGCAGTTCGACCGCCTGTGGGCCGTCAACGCGAAGGCACCGTACTTCCTGGTGCAGCGGGCCCTGGCCCACCTCCCCGACGGGGGGCGGATCATCAACATCTCCTCGGGGCTGACCCGGGTCGCCAACCCTCAGGAGATTGCGTACGCGATGACCAAGGGCGCGGTCGACCAGCTCACCCTGCACTTCGCCAAGCACCTCGGACCGCGCGGCATCACGGTGAACAGCGTGGGCCCAGGCATCACCGACAACGGTTCCGCCGTCTTCAGCGACCCGGAGGCGGTGGCCGCGATGGCGGGCTACTCGGTGTTCAACCGGGTCGGTGAGGCCCGCGACATCGCCGATGTGGTGGCCTTCCTGGCGAGTGACGACTCGCGCTGGATCACCGGCTCCTACCTGGACGCCAGCGGCGGCACCCTCCTCGGCGGCTGA	MTAPDTDVVVVGAGPTGLMLAGDLRAGGARVTVLERLERPTTESRASVLHARTMELLAERGLLERFGPLPEAGPGHFGGIPLDLSEAGNSPYAGQWKAPQTHVEAVLAAWARELGVEVRRGLTVTGLAQRADRVRVVAVAPDGRRLRLDAAYVIGCDGEDSTVRRLGNFAFPGVDSGKELLRADLAGIELRERRFERHPRGVANARRGPDGVTRIMVHAFDRTPGPSGTPAFADVCAVWAHVTGEDISAARPVWLNAFGNARRQADRYRDGRVFLAGDAAHVQLPVGGQALNLGLQDAMDLGPKLAARLAGRAGDEVLDSYGLVRRAVGARVLTNIEAQAQLLFGGPEVDPLREVFRELLELPAARRHLGAMVGGLDGGRPARAGAGGPAVSVAPAPLRQDITHRRITMGKLSGKTALVSGSSRGIGRATALRLARDGALVAVHCSSNRAAAEETVAAVEKDGGRAFSVVAELGVPGDVHELFLALERELKERTGTTTLDILVNNAGVMGGVDPEELTPEQFDRLWAVNAKAPYFLVQRALAHLPDGGRIINISSGLTRVANPQEIAYAMTKGAVDQLTLHFAKHLGPRGITVNSVGPGITDNGSAVFSDPEAVAAMAGYSVFNRVGEARDIADVVAFLASDDSRWITGSYLDASGGTLLGG	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	139.08	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1104	rifampin; rifaximin; rifapentine
BGC0000229.1|Grincamycin_19 # 17936 # 19153 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.742	BGC0000229.1|Grincamycin_19 	17936	19153	+	Loose	1000	77.0258	efpA	33.33	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGAACCTCTTCACCTCCCCGCGCCCCGGCCCCGCCCTGGCCGGTCGGCGGGCCCTGCTGTTCGTACTCGCCGGCAACATGCTCGTCGACGCCCTGGAGGTCTCCGTCGTCCTGGTCGCCCTGCCGCCCATGGGGCGGGACCTGGGACTGTCCATGTTCGGCGGGCAGTGGATGATGAGCGGCTTCGCCGCGGGGTTCGCCGCCCTGCTGCTGCTCGGCCCGCGTCTTGCCGCCCTGTGGGGACGACGGCCCGTGTACCTCGCCGCGCTGACGGTGTTCATCGCCGCCTCGCTGGCCGGCGGCCTGACGGACGAGGGCGCCGTGCTGGCCGCGACCAGGGTGGTGAAGGGCATGTGCGCGGCGCTGACCGCGCCCACCGGGCTGGCCATCATCGGCACCGTCTTCCGGCCAGGGCGGGAACAGAGCCGGGCGGTGTCCGTGTACTCCCTCTTCGGAGCGGCGGGGTTCACGGTCGGCCTGCTCTCCTCCGGTGCGCTCACCGAGCTGAGCTGGCGCTGGACTCCGGTGTTCCCCGGGTCGTTCGCCCTCCTCCTGCTGCTGGCCGGTCTCCGGCTCGTCCCCCGGGACGCCGGGCCCCCATCCGCCGAGCCGCTGCTGCCGGCCCTGATCCGGCTGGTGCGCAACGGTCCGTTCGTGCGGTCGGCGCTGTGCGCGGCGACACTCAACGGCACCTACCTCGGGCTGCTGCTGCTCCTCACCCACTGGCTGCACGACACCTGGGGGTGGGGCTCCTGGGAGACGGCGCTGGCGTTCCTGCCGGCGTGTGTGCCGCTGGCCCTCACCCTGCCGTTCGCCGACCGGATGGTGGCGCGCTTCGGCACCGCACGGCTGATCGCGGCCGGAGGGTGCGCCACGGCGCTGGGCTGTGTGACGGCGCTGCTGACCGGAGCGCCGGACACCTACGTCACCGGGGTGCTGCCGGTGCTGCTCTGCGTCGAGGCGGGTTTCGTGCTGTCCTTCGCAGCCCTCAATCTCCAGGCCGTGTCGGGCATTCCGGCCGCAGAACGGGGCACCGCGGTGCCGGTCTACCAGACGGCGGTTCAGCTGGGCCCCCTGCTGTCGCTGCCGGCGGTGGCCATGGCGGCGGGTGCGGGTTACCGCCCGGCGCTGCTGTTCCTGACGGCGCTGGCGACGACGGGGGCCGTGACCGCCTGCGCCCCGCGCCGCCGCGCCCGTCCCGCCATCGCGGCCTGA	MPNLFTSPRPGPALAGRRALLFVLAGNMLVDALEVSVVLVALPPMGRDLGLSMFGGQWMMSGFAAGFAALLLLGPRLAALWGRRPVYLAALTVFIAASLAGGLTDEGAVLAATRVVKGMCAALTAPTGLAIIGTVFRPGREQSRAVSVYSLFGAAGFTVGLLSSGALTELSWRWTPVFPGSFALLLLLAGLRLVPRDAGPPSAEPLLPALIRLVRNGPFVRSALCAATLNGTYLGLLLLLTHWLHDTWGWGSWETALAFLPACVPLALTLPFADRMVARFGTARLIAAGGCATALGCVTALLTGAPDTYVTGVLPVLLCVEAGFVLSFAALNLQAVSGIPAAERGTAVPVYQTAVQLGPLLSLPAVAMAAGAGYRPALLFLTALATTGAVTACAPRRRARPAIAA	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	76.42	gnl|BL_ORD_ID|2188|hsp_num:0	2427			156	624	rifampin; isoniazid
BGC0000229.1|Grincamycin_20 # 19194 # 20486 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.716	BGC0000229.1|Grincamycin_20 	19194	20486	+	Loose	700	46.9802	oleI	25.82	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGTGTCCTGTTCACCATCTTTCCGGCGACGGCGCACCTGTATCCGGTGGTGCCGCTGGCCTGGGCGCTGCAGAGCGCCGGGCACGAGGTCGTCGTGGCGAGTCACGCGGGCGTCGTGGACCCCGGGGTGATCGACAACATCGCCGCGGCGGGGCTCACGGCCGTACCGCTGGGCACGCCGGACGAACTGCCGGAAGCCCTCGGCCCGCACACGGGCGACGCCGAGCCGGACCGGCCCTCCCTGGGGTTCGACGCCTTCGAACCGGAGGAGACGGGGTCCTGGCGCACCACTCGCGCCATTCTGACCGGCATGTTCCGGCTGCACTACCCGGAGCCTTCCGAGCCGGGCGCCCGCCGGCCGGTGCTGGACAACCTGGTCGACTTCGCCCGTGCCTGGCGTCCCGACCTGGTGCTGTGGGATCCGCTGATGTTCCCCGCCCCCGTCGCCGCGCGGGTCAGCGGCGCGGCGCACGCCCGGCTGCTGTGGGGGATGGACAACATCGGCGTGATCCATGAGCGCACGAAGCGTGAACTGGCGGATCCGGCGTCGGAGCTGACGGAGCATCCGTGGCTGAGCTGGTTCGGCCCGGTTCTGGAGCGCCACGGGCTGGAGTTCGGCGACGAGATGCTGCTCGGCCAGTGGACGCTGGACCTCACCCAGTCCCGGATGCAGGCTCCGCTCGACCAGACGCGCATACCGGTGCGGAGGGTCCCGTACACCGGCGCCGGCCGCCTCCCGGGCTGGCTGCACACCCGTCCCGGGCGTCCCCGGGCGGTGCTGTCCCTGGGCGTGAGCCGACGCAAGATCTTCGGCAAGTACAGCGGGTTCCCCCTGCGTGAGTTCTTCGCGTCGGTGTCGGAGCTGGACATCGAGGTCGTCGCCACGCTGAACAGCCAGCAGCTCGACGCGGCGGGCACGCTGCCCGGCAATGTGCGCGCCCTGGAGTACGTCCCGCTCAACCAGGTTCTGCCGACCGCTTCGGCGATCGTCCACCACGGTGGAGGCGGCACGTTCTCCTCCGCCGTCGCCCACCGCGTGCCCCAGCTGGTGATGCCGCTGGTCATGTGGGACGAGATGGTCACCGCCCGCTACGTGCGGGACATGGGAGCGGGCCTGGTCGCCGACCCGGACGCCCTGGACGTCGCGGAGATGCACAAGCAGCTCGTACGGCTGCTGGAGGATCCGTCGTTCCAGCTGGGCGCCCGCCGCCTGCACGACGAGATGCTCGCCGCGCCCGCGCCCAAGGAGATCGTGCCGCTGCTGGAGCGGCTGACCGCCGAACGCCGCTGA	MRVLFTIFPATAHLYPVVPLAWALQSAGHEVVVASHAGVVDPGVIDNIAAAGLTAVPLGTPDELPEALGPHTGDAEPDRPSLGFDAFEPEETGSWRTTRAILTGMFRLHYPEPSEPGARRPVLDNLVDFARAWRPDLVLWDPLMFPAPVAARVSGAAHARLLWGMDNIGVIHERTKRELADPASELTEHPWLSWFGPVLERHGLEFGDEMLLGQWTLDLTQSRMQAPLDQTRIPVRRVPYTGAGRLPGWLHTRPGRPRAVLSLGVSRRKIFGKYSGFPLREFFASVSELDIEVVATLNSQQLDAAGTLPGNVRALEYVPLNQVLPTASAIVHHGGGGTFSSAVAHRVPQLVMPLVMWDEMVTARYVRDMGAGLVADPDALDVAEMHKQLVRLLEDPSFQLGARRLHDEMLAAPAPKEIVPLLERLTAERR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	101.42	gnl|BL_ORD_ID|1684|hsp_num:0	1824			741	1266	oleandomycin
BGC0000229.1|Grincamycin_21 # 20516 # 21730 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.741	BGC0000229.1|Grincamycin_21 	20516	21730	+	Loose	700	62.003	oleD	25.0	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTACTGGTGATCTCCACCCCCGTTCCCACCCATTTCCTTCCGTTGGTGCCGCTGTTGTGGGCGCTGCGCTCGGCCGGTCACGAGGTGACCGTGCTGGCCCAGCCCGATGTGGTCGGAGCCGTACGGGCCTGCGGTCTCACGGCGATCTCGGCGGGCGAGCCGTTCGAGGTGAACGGGATGCTGCTGGAGGGGCTGGAGCCGGAGCGGCGTCCGCTGCAGGCACGGCCCCGGCCGGCCCCCGAACTGCTCGGCGGGTACGGCAGGTTGTGGTGGGCCCACGCCGCCTCGATGCTCGACGGCTACAGCGACGTGGCCGAGAGGTACCGGCCGGATCTCGTCCTGGCCGACCCGCTGGAGTACTGCTCGCTGATCATCGGGGCACGGCTGGGTGTGCCGGTCGTGCACCACCGGTGGGCGGTGGACGCCATCTCCGGACCTGCCCGGGCCTTCGTCCGCCCCGGCGCCCGTGAGCTGTGCGAGCGGCTCGGCCTTCCCGGCCTGCCCGACCCGGACGTGCTGCTCGACCCGTGTCCGCCTTCGCTGCGGCTGCCGGGCGGCGAACCGGGCACGCCCATCCGGTACGTGCCGTACAGCGGGGGCGCAGAGGTTCCCGCCTGGGTACGGGCCGACCGCGGTCCGGGAGCGGAGCGGCGGCGGGTGGCCGTGTCGCTGGGCAACACCCTGGCCCTGCACGGTGTGGGTTTCACCCGCGGTCTGCTGCGGGCCCTCGCCGCGCGGCCCGGGACCGAGATCCTGGTGACGCTGCCCGAGCCGTACCGCACGCGGATCGGTCCGCTGCCGAGCGGGGTCACGGCGGTCGACCCGCTCCCCCTGCACCTGTTCCTCGGCACCTGTGACGCGATGGTCCACCACGGGGGCGCCGGCACGGCCATGACGGCGACCTCCTTCGGACTGCCCCAGTTGGTGCTTCCGCAGCTGGCGGACCACTTCCCGCTGGGCGACCGGCTCACCGCGGCCGGCGCCGGGCTGTCCTTCGACACGGCGGAACGGCAGGACGACCCGCGGACCGTCGGCGCGGCCCTGGACGAGCTGCTGTCCGACCCCCGATACGCCGACGCGGCCCGTGGTCTGGCCGCGGAGATGGCCCGTATGCCGTCCCCCGTCGCCGCGGCCGCCGATCTTGAGCGGCGGGCCCGGGCGGGCACCCGACCGAGAAAGGCGAGCCTCCAGTGCACATCGAGGAACTGA	MRVLVISTPVPTHFLPLVPLLWALRSAGHEVTVLAQPDVVGAVRACGLTAISAGEPFEVNGMLLEGLEPERRPLQARPRPAPELLGGYGRLWWAHAASMLDGYSDVAERYRPDLVLADPLEYCSLIIGARLGVPVVHHRWAVDAISGPARAFVRPGARELCERLGLPGLPDPDVLLDPCPPSLRLPGGEPGTPIRYVPYSGGAEVPAWVRADRGPGAERRRVAVSLGNTLALHGVGFTRGLLRALAARPGTEILVTLPEPYRTRIGPLPSGVTAVDPLPLHLFLGTCDAMVHHGGAGTAMTATSFGLPQLVLPQLADHFPLGDRLTAAGAGLSFDTAERQDDPRTVGAALDELLSDPRYADAARGLAAEMARMPSPVAAAADLERRARAGTRPRKASLQCTSRN	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	97.35	gnl|BL_ORD_ID|1253|hsp_num:0	1367			24	1149	erythromycin; tylosin
BGC0000229.1|Grincamycin_23 # 22296 # 23426 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000229.1|Grincamycin_23 	22296	23426	+	Loose	700	43.8986	oleI	25.15	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCTCTTCGTCGCCGCGGGAAGCCCGGCGACCGTGTTCGCCCTGGCCCCGCTGGCCACCGCCGCGCGCAACGCGGGACACCAGGTGGTGATGGCCGCGAACGACGACATGGTCCCGTACATCACGTCGTCGGGCCTGCCGGGCGTGGCGACCACCGATCTGCCGATCCGGCACTTCATCACCACCGACCGGGCCGGCCGTCCCGAGGCGATCCCCTCCGGCCCGGTGGAGCAGGCGCTGTTCACCGGCCGCTGGTTCGCGCGCATGGCCGCGTCGAGCCTGCCCCGGATGCTGGACTTCTGCCGGTCCTGGCGGCCCGATCTGATCGTCGGCGGCACCATGAGCTACGTCGCTCCGCTGCTCGCCCTGCACCTGGGCGTGCCGCACGTGCGACAGACCTGGGACGCCATCGAGGCGGACGGCATTCACCCGGGCGCGGACGCCGAACTGCGGCCGGAGCTGGAACGGTTCGGGCTGGACCGGCTGCCAGGACCGGACCTGCTCGTGGACATCTGCCCACCGAGCCTGCGTCCGGGGAACGCCGCCCCCGCACAGCCCATGCGCTACGTCCCGGCGAACGCCCAGCGGCGGCTGGAGACCTGGATGTTCACCCGCGGCGAGCGCCGCAGGATCCTCGTCACCTCGGGCAGCCGGGTCGCGAAGGAGAGCTACGACAAGAACTTCGACTTCCTGCGCGGCCTTGCCTCGGAGGTCGCCTCGTGGGACGTCGAACTGATCGTCGCCGCGCCCGACGGGGCCGCCGACGCGCTGCGCGACGGCCTGCCGGGGGTCCCCGTCGGCTGGGCGCCTCTGGACCTGGTGGCGCCCACCTGTGACCTGCTGGTGCACCACGCGGGCGGGGTGAGCACCCTGACCGGTCTGAACGCCGGTGTACCGCAACTCCTCATTCCCAAGGGCGCCGTGCTGGAGAAGCCCGCCCTGCGCGTCGCGGACCGCGGTGCGGCGATCACGCTGCTGCCGGGCGAGGACTCGGTCGACGCGGTCGCGGACTCCTGCCAGGAGCTGCTGGCCAAGGACACCTACCGGGAGGCGGCGGGTGCCCTCTCCCGCGAGATCGCCGCCATGCCCTCCCCCGCGAGCGTGGTCGCCGCGCTCGGAGATCTGGCGTGA	MLFVAAGSPATVFALAPLATAARNAGHQVVMAANDDMVPYITSSGLPGVATTDLPIRHFITTDRAGRPEAIPSGPVEQALFTGRWFARMAASSLPRMLDFCRSWRPDLIVGGTMSYVAPLLALHLGVPHVRQTWDAIEADGIHPGADAELRPELERFGLDRLPGPDLLVDICPPSLRPGNAAPAQPMRYVPANAQRRLETWMFTRGERRRILVTSGSRVAKESYDKNFDFLRGLASEVASWDVELIVAAPDGAADALRDGLPGVPVGWAPLDLVAPTCDLLVHHAGGVSTLTGLNAGVPQLLIPKGAVLEKPALRVADRGAAITLLPGEDSVDAVADSCQELLAKDTYREAAGALSREIAAMPSPASVVAALGDLA	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	88.68	gnl|BL_ORD_ID|1684|hsp_num:0	1824			117	1092	oleandomycin
BGC0000229.1|Grincamycin_24 # 23455 # 24522 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.699	BGC0000229.1|Grincamycin_24 	23455	24522	+	Loose	520	28.1054	OXA-276	23.08	3001732	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGGCTCTGGTGCTAGCAGGCGGGTCCGGTACCCGCCTGCGGCCTTTCAGCTACTCGATGCCCAAACAACTCATACCCATCGCCAACACACCGGTCCTGGTGCACGTGCTCGGCTCCGTCCGGGAGCTGGGCGTGACCGAGGTGGGTGTCATCGTCGGCAACCGCGGGCCGGAGATCGAGGCGGTCCTCGGCGACGGCTCCCGGTTCGGCGTGCACATCACCTACATCGCCCAGGACGAGCCGCGAGGACTGGCCCACACCGTGGTGATCGCCCGGGACTTCCTCGGCCCGGACGACTTCGTGATGTACCTGGGAGACAACATGCTGCCCGACGGCATCGTCCCCATCGCCGAGGAGTTCGCCCGGCACCGCCCGGCCGCGCACGTCGTCGTGCACAAGGTCGCCGACCCTCGCTCGTTCGGCGTCGCCGAGCTGGGGCCGGACGGCGAGGTGCGGCGTCTGGTCGAGAAGCCCCGGGAGCCGCGCAGCGACCTGGCGCTGATCGGTGTCTACTTCTTCACCGCCGCCATCCACGAGGCGGTGGCGTCCATCGGGCCGAGCGTCCGCGGCGAACTGGAGATCACCGACGCCGTTCAGTGGCTCGTGTCCTCCGGTGCGGAGGTGCGGGCCAGCCGCTACGACGGCTACTGGAAAGACACCGGAAAGGTCGAGGACGTCCTGGAGTGCAACAGCCACCTCCTCGACGGACTGACCCGGCGCGTCGACGGACGGGTCGACGACGACAGCGTGCTCGTCGGCCGAGTCGTGGTCGAGGCCGGCGCTCGCGTCGTCAGGTCCCGGGTGGAGGGCCCGGCCATCATCGGCGCGGGCACGGTGCTGGAGGACAGCCACATCGGCCCGCACACCTCCATCGGGCGGGACTGCCTGGTGACGGACAGCAGGCTCGAGGGCTCGATCGCCCTGGACGAGGCGTCCGTCACCGGTGTACACGGCCTGCGCAACTCGCTCATCGGGCGCGCCGCGTCCGTGGGCACCACGGGACGGGGCACCGACCATCACTGCCTCGTCGTGGGAGATCACACACGAGTGGAGGTCGCGGCATGA	MKALVLAGGSGTRLRPFSYSMPKQLIPIANTPVLVHVLGSVRELGVTEVGVIVGNRGPEIEAVLGDGSRFGVHITYIAQDEPRGLAHTVVIARDFLGPDDFVMYLGDNMLPDGIVPIAEEFARHRPAAHVVVHKVADPRSFGVAELGPDGEVRRLVEKPREPRSDLALIGVYFFTAAIHEAVASIGPSVRGELEITDAVQWLVSSGAEVRASRYDGYWKDTGKVEDVLECNSHLLDGLTRRVDGRVDDDSVLVGRVVVEAGARVVRSRVEGPAIIGAGTVLEDSHIGPHTSIGRDCLVTDSRLEGSIALDEASVTGVHGLRNSLIGRAASVGTTGRGTDHHCLVVGDHTRVEVAA	MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQVYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKVTPKQEVEFASALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG	128.62	gnl|BL_ORD_ID|2569|hsp_num:0	3442			57	402	cloxacillin; oxacillin; cefalotin
BGC0000229.1|Grincamycin_25 # 24519 # 25502 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.687	BGC0000229.1|Grincamycin_25 	24519	25502	+	Loose	1200	45.0542	arnA	25.15	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGGATCCTCGTCACCGGAGCGGCGGGCTTCATCGGCTCACACTTCGTCCGCAGTCTGCTGGCGGACGAGTACCGCGGCTGGGAAGGCGCCCACGTCACCGCCCTGGACAAGCTGACCTACGCCGGCAACCGGGAGAACCTGCCCGCCTCGCACGAACGTCTGGTGTTCGTACGGGGCGACGTGTGCGACCGGTCCCTGCTCCGCGAACTGCTGCCCGGTCACGACGCCGTGGTGCACTTCGCGGCCGAGTCCCATGTGGACCGGTCGCTCGAAGGAGCCGGGGAGTTCTTCCGGACGAACGTGCTGGGCACCCAGACCCTGCTGGACGCGGTGCTGGAGAGCGGGGTCGAGCGGGTCGTCCACGTCTCCACCGACGAGGTCTACGGCTCGATCGCGGAGGGCTCCTGGACGGAGGAGTGGCCGCTGGCGCCCAACTCGCCCTACGCGGCCTCGAAGGCCGGCTCGGACCTGGTCGCCCGCGCGTACTGGCGGACCCACGGTGTGGACCTGTCGGTCACCCGCTGCTCCAACAACTACGGCCCCTACCAGCACCCCGAGAAGGTCATCCCGCTCTTCGTGACCAATCTGCTGGAGGGCGGCCAGGTCCCCCTGTACGGGGACGGACGCAACGTCCGCGAGTGGCTGCACGTGGCCGACCACTGCCGTGGCATCCACCTGGTGCTCAACGAGGGCCGGGCCGGGGAGATCTACAACATCGGCGGCGGCAACGAGTACACCAACCTCGACCTCACCCGGAAGCTGCTGGAACTGACCGGCGCCGGCGAGGAGAAGATCCGCCGGGTGGCCGACCGCAAGGCACACGACCTGCGCTACTCGATCGACGAGTCGAAGATCCGTCAGGAGCTGGGCTACACACCCCGGATCGGGTTCGAGGAGGGTCTTGCGGAGACCGTCGCCTGGTACCGCGACAACCCGGACTGGTGGAAGGCCGTGAAGCACGGGACGAGCCGTGCGGCCTGA	MRILVTGAAGFIGSHFVRSLLADEYRGWEGAHVTALDKLTYAGNRENLPASHERLVFVRGDVCDRSLLRELLPGHDAVVHFAAESHVDRSLEGAGEFFRTNVLGTQTLLDAVLESGVERVVHVSTDEVYGSIAEGSWTEEWPLAPNSPYAASKAGSDLVARAYWRTHGVDLSVTRCSNNYGPYQHPEKVIPLFVTNLLEGGQVPLYGDGRNVREWLHVADHCRGIHLVLNEGRAGEIYNIGGGNEYTNLDLTRKLLELTGAGEEKIRRVADRKAHDLRYSIDESKIRQELGYTPRIGFEEGLAETVAWYRDNPDWWKAVKHGTSRAA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.40	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1836	polymyxin B
BGC0000229.1|Grincamycin_26 # 25513 # 26547 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0000229.1|Grincamycin_26 	25513	26547	+	Loose	600	28.4906	ICR-Mc	31.82	3004466	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	GTGCCGGGGCTGTCGGTCGTGATCCTGGGGAGCAGCGGTTTCCTGGGCCGTGGGCTCGGCGCGGCGTTCGCCGCGCGGGGCGCGCGGGTGCACGGCGTCTCCCGAGGCGGTCCGCCGCCGGGCGCCGGTCCGTCATCGGGCCGGACCACGACAGCCACGTGCCTGGACCTGCTGACGGCGGCCTCGGGTGAGCTGCGGGCGGCCTTCTCCGCGGCCCGCCCGGACGTCGTGGTGAACGCGGCGGGCCGGGCCTGGCGGGCGGACGAGGCGGAGATGAACGCGGGCAACGCCGTACTCGTCGAGCGGGTCGTGACAGCACTCGCCGAACTGCCCGGTCCTCCGGTGCGGCTGGTGCAGCTGGGCAGCGTCCACGAGTACGGCGCCGGCGACCCGGCCGGCGGCACGGGCGAGAGGCACGACCCCGACCCGGTCACGCCCTACGGCCGTACCAAACTCCTCGGGACGCGGGCCGTGCTGCGCGGCGCGCGGGAGGGAAGCGTCGAAGGAGTGGTGCTCCGGCTCGCCAACGTGATCGGCGCCGGGGTGCCCGAGGGCAGTCTCTTCGGCAGGGTGGCGGCCCATCTCGGTGCGTCGGCGGCGGCGCGGGCACGTGGGGAGCAGGTCACCGCCCTGCGGCTTCCGCCGCTGCGCGCGGCCCGTGACCTGGTGGACGCCCGTGACGTCGCCGACGCGGTGGTGGCCGCGGCCTCTGCTCCGTCCGCGGCCGTGACCGGCCAGGTGATCAACGTGGGCCGCGGCGAGGCGGTCGTCATGCGTGCGCTGATCGACCGGATGATCGCGCTCAGCGGTGTGGACGTCCCGGTGACCGAGGCGGCCGAGGCGCCGGCACGCACCGACGTGGCCCGCCAGTGTCTGGACATCTCCCGTGCCCGGCGGCTGCTCGGCTGGAGCCCCTCTCGCGGACTCGACGACTCCCTGCGCGACCTCCTCGCCTCCGTGCTGCCGCCGGAGCGTCCGTCGCACAGCACACCACTCGGCATCACGGCCGCATCCCCGGCCGGAGAAGGGAATTGA	MPGLSVVILGSSGFLGRGLGAAFAARGARVHGVSRGGPPPGAGPSSGRTTTATCLDLLTAASGELRAAFSAARPDVVVNAAGRAWRADEAEMNAGNAVLVERVVTALAELPGPPVRLVQLGSVHEYGAGDPAGGTGERHDPDPVTPYGRTKLLGTRAVLRGAREGSVEGVVLRLANVIGAGVPEGSLFGRVAAHLGASAAARARGEQVTALRLPPLRAARDLVDARDVADAVVAAASAPSAAVTGQVINVGRGEAVVMRALIDRMIALSGVDVPVTEAAEAPARTDVARQCLDISRARRLLGWSPSRGLDDSLRDLLASVLPPERPSHSTPLGITAASPAGEGN	MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD	59.52	gnl|BL_ORD_ID|2509|hsp_num:0	2902			465	597	colistin A; colistin B
BGC0000229.1|Grincamycin_27 # 26550 # 27854 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=13bp;gc_cont=0.687	BGC0000229.1|Grincamycin_27 	26550	27854	+	Loose	1000	30.4166	efpA	26.03	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGAGCGCAAGAACCGGATCCTCGAAGAGGTCCGCGCATACCACCAGGAGACCGCCCCGGCACGGGAGTTCGTCCCGGGGACGACGGAGATCTGGCCGTCCGGGGCGGTACTGGAGGACGAGGACCGGGTGGCTCTGGTGGAGGCCGCGCTGGAGATGCGGATCGCCGCCGGGACCAGCTCCCGCAAGTTCGAGTCGCAGTTCGCACGACGCCTCAAGCGCCGCAAGGCTCATCTGACCAACTCCGGTTCGTCGGCGAACCTGCTGGCCGTGTCGGCTCTGATGTCGCACGCCCTGGAGGAGCGGCGGCTGCGGCCGGGCGACGAGGTCGTCACGGTCGCGGCCGGCTTCCCGACCACGGTCAACCCGATCCTGCAGAACGGCCTGATCCCGGTCTTCGTGGACGTGGACCTGGCCACCTGCAACGCGACGGCCGACCGGGTGGCCGCGGCGATCGGGCCGAAGACCCGCGCCGTCGTCATCGCGCACGCGCTGGGCAATCCCTTCGAGGTCGCGGAGATCGCCCAGCTCTGCGAACAGCACGACCTGTTCCTGATCGAGGACAACTGCGACGCGGTCGGCTCCCTCTACGACGGGCAGCTCACCGGCACCTTCGGCGACATGACGACGGTCAGCTTCTACCCTGCGCACCATCTGACCATGGGCGAGGGCGGCTGCGTGCTGACCTCCAACCTGGCCCTGGCCCGCATCGTCGAGTCCCTGCGCGACTGGGGCCGGGACTGCTGGTGCGAACCCGGTGAGAACGACCGCTGCCTGAAGCGGTTCACGTACCAGATGGGCACGCTGCCGGCCGGGTACGACCACAAGTACATCTTCTCCCACGTGGGGTACAACCTGAAGGCCACGGACATCCAGGCCGCACTGGGGCTGACCCAGCTGGCCAAGCTGGACTCGTTCATAGAGGCGCGCCGGCGCAACTGGCGGCGGCTGCGTGAGGGACTCGACGGCGTCCCCGGCCTGCTGCTGCCCGAGGCCACCCCCCGCTCCGAGCCCAGTTGGTTCGGCTTCGTCATCACCGTGGACCCCGAAGCGCCGTTCAGCCGGGCCGAGCTGGTCGATTTCCTGGAGGGCCGCAAGATCGGCACGCGTCGACTCTTCGCCGGGAATCTGACCCGTCACCCGGCCTACATCGACCAGCCGCACCGGATCGTGGGCGACCTGGCCAACAGCGACGTCATCACCGAGCACACCTTCTGGATCGGGGTCTACCCGGCGCTCACGGACGAGATGCTGGACTACGTCACCGCCTCGATCAAGGAGTTCGTGGCCGCGCGCGGCTGA	MSERKNRILEEVRAYHQETAPAREFVPGTTEIWPSGAVLEDEDRVALVEAALEMRIAAGTSSRKFESQFARRLKRRKAHLTNSGSSANLLAVSALMSHALEERRLRPGDEVVTVAAGFPTTVNPILQNGLIPVFVDVDLATCNATADRVAAAIGPKTRAVVIAHALGNPFEVAEIAQLCEQHDLFLIEDNCDAVGSLYDGQLTGTFGDMTTVSFYPAHHLTMGEGGCVLTSNLALARIVESLRDWGRDCWCEPGENDRCLKRFTYQMGTLPAGYDHKYIFSHVGYNLKATDIQAALGLTQLAKLDSFIEARRRNWRRLREGLDGVPGLLLPEATPRSEPSWFGFVITVDPEAPFSRAELVDFLEGRKIGTRRLFAGNLTRHPAYIDQPHRIVGDLANSDVITEHTFWIGVYPALTDEMLDYVTASIKEFVAARG	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	81.89	gnl|BL_ORD_ID|2188|hsp_num:0	2427			1191	1395	rifampin; isoniazid
BGC0000229.1|Grincamycin_28 # 27907 # 28671 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=13bp;gc_cont=0.722	BGC0000229.1|Grincamycin_28 	27907	28671	+	Loose	850	25.409	opmE	34.78	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACATTGTGGGAAACGGTTTCCTGGCGCGGAACCTGCGCCCGCTGGCCGGCCGGCACCCGGACACGGTGGCCCTGGCGGCCGGGGTGTCGTGGGCCGGCGGCACCTCCGACGCGGACTTCGCCCGCGAGGAGGCTCTGCTGCACGAGGTCGCCGGCAGGTGCCGCGACACAGGCCGGCGGCTGCTCTTCTTCTCCACCGCGGCGACCGGCATGTACGGACTCGCCGACGGACCCGGCCGGGAGGATGTCCCGGTGACCCCCTGCACTCCCTACGGCGCGCACAAGCTCGCCCTGGAGGGAGTGCTGCGCGACTCCGGCGCCGACCATCTGATCCTCCGGCTGGGGCATCTGGTCGGCCCGCACCAGCCCGAACACCAGCTGCTGCCCACCTTGGTACGGCAGTTGCGCGAGGGTGTGGTCCGGGTGCACCGCGGCGCGGCCCGGGACCTGATCGGCGTCGAGGACGTCGTCACCGTGGTCGACCATCTCCTCGCCACCGGCCTGCGGGCCGAGACGGTCAACGTCGCTTCGGGTTTCGCCGTACCGGTGGAGGACATCGTCGATCACCTCGAAGAGGCTCTCGGGCTGCGGGCACGCCGGGAGTTCGTCCGGACGGGCGGCCGTCAGCACGTCATCTCGACGGAGAAGCTGCGCGCCCTCGTGCCGCAGACCGCGCGCATGGGGTTCGGCCCCGCCTACTACCGGCGGATCCTCGGGGACTTCACGGCCTCCGTGGCATCCGACGCCTCCGCACCTGCCTGA	MDIVGNGFLARNLRPLAGRHPDTVALAAGVSWAGGTSDADFAREEALLHEVAGRCRDTGRRLLFFSTAATGMYGLADGPGREDVPVTPCTPYGAHKLALEGVLRDSGADHLILRLGHLVGPHQPEHQLLPTLVRQLREGVVRVHRGAARDLIGVEDVVTVVDHLLATGLRAETVNVASGFAVPVEDIVDHLEEALGLRARREFVRTGGRQHVISTEKLRALVPQTARMGFGPAYYRRILGDFTASVASDASAPA	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	51.73	gnl|BL_ORD_ID|2019|hsp_num:0	2213			573	711	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000229.1|Grincamycin_30 # 29709 # 31112 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.687	BGC0000229.1|Grincamycin_30 	29709	31112	+	Loose	1500	27.7202	rphA	26.67	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGACGCCACCTCCCCTCCCGCAAGCCCGCGACAACACCCGGCGGATGACGGAACGTCTCGGGCTTTCCTCCGCCACCTTCCACGGCTCCCATCTGCCGACCGACCGCTTCTCCGCATGGCTCGCCGAGCGTGGCAGCGTCAACGCGTTCCGTGTGGACCGGATCCCGTTCGCCGAGCTGGACGGATGGTCGTTCGAGGACACCACCGGCAATCTCGTGCACCGCAGCGGCAGGTTCTTCACCGTCGAGGGCATGCGGGTGACCGAGCGCGACGAACCCTACGGCGACGGCCCGTACGCCGAGTGGCACCAACCCGTCATCAAGCAGCCCGAGGTAGGCATCCTGGGCATCCTGGCCAAGGAGTTCGACGGGGTCCTGCACTTCCTGATGCAGGCCAAGATGGAACCCGGCAACCCCAACCTTCTCCAGCTGTCCCCCACGGTGCAGGCCACCCGCAGCAACTACACCAAGGCCCACCAAGGCGCCGACGTGAAGTACATGGAACACTTCGTCGGCCCTCGACGGGGCCGGGTCGTCGCGGACTCCCTGCAGTCCGAGCACGGTTCGTGGTTCTTCCGTAAGTCCAACCGCAACATGATCGTGGAGGCCACCGGTGACGTGCCGCTCCTGGACGACTTCTGCTGGCTGACCCTGGGACAGATCGCCGAACTGCTCCACCGGGACAATGTCGTCAACATGGACTCGCGAACGGTCCTGTCCTGCCTGCCGGTCCCGGAGACGGCGGCCGGCGCCCTGCACTCCGACACCGAACTGCTGTCCTGGATCACCGGCGAGCGCGCCCGGCACGATGTGCACGCCGAGCGTGTCCCGCTGGCCGGCCTGCCCGGGTGGCGCCGGCACGAGACGGCCGTCGAGCACGAGGAGGGCCGGTACTTCAAGGTGGTGGCGGTGTCGGTGCAGGCCGGCAACCGCGAGGTCACCAGCTGGACCCAGCCGCTGTTCGAACCGGTCGGCCTCGGTGTGACCGCCTTCCTCACCCGCACCTTCGACGGCGTACCGCACGTGCTGGTGCACGCCCGGGTCGAGGGAGGCTTCCTCGACACCGTCGAACTGGGCCCCACGGTCCAGTACACCCCCGACAACTACGCCCATCTGCCGGAGAAGGAACGCCCGCCGTTCCTCGACACCGTGCTGGAGGCACCGGCGGAGCGGATCCGCTACGAGGCCGTGCACGCGGAGGAAGGCGGCCGGTTCCTCAACGCGGAGAGCCGGTACCTGCTCGTCGACGCCGACGAACGGGACGCCCCGCTCGAACCGCCGCCCGGGTACGCCTGGGTCAGTCCCGACCAGCTGACCTGGCTGGTCCGTCACGGCCACTATCTGAACGTCCAGGCGCGGACACTGCTCGCCTGCCTCAACGCCGCCAAGGCGGCGGTCCGATGA	MTPPPLPQARDNTRRMTERLGLSSATFHGSHLPTDRFSAWLAERGSVNAFRVDRIPFAELDGWSFEDTTGNLVHRSGRFFTVEGMRVTERDEPYGDGPYAEWHQPVIKQPEVGILGILAKEFDGVLHFLMQAKMEPGNPNLLQLSPTVQATRSNYTKAHQGADVKYMEHFVGPRRGRVVADSLQSEHGSWFFRKSNRNMIVEATGDVPLLDDFCWLTLGQIAELLHRDNVVNMDSRTVLSCLPVPETAAGALHSDTELLSWITGERARHDVHAERVPLAGLPGWRRHETAVEHEEGRYFKVVAVSVQAGNREVTSWTQPLFEPVGLGVTAFLTRTFDGVPHVLVHARVEGGFLDTVELGPTVQYTPDNYAHLPEKERPPFLDTVLEAPAERIRYEAVHAEEGGRFLNAESRYLLVDADERDAPLEPPPGYAWVSPDQLTWLVRHGHYLNVQARTLLACLNAAKAAVR	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	53.99	gnl|BL_ORD_ID|890|hsp_num:0	910			2271	2496	rifampin; rifaximin; rifabutin; rifapentine
BGC0000229.1|Grincamycin_31 # 31109 # 32068 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000229.1|Grincamycin_31 	31109	32068	+	Loose	750	28.1054	adeA	30.77	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGCGCCGGTGTCCATCGGGGTGCTCGGCTGCGCCGACATCGCGGTACGACGGATGCTGCCCGCGTTCACCGCCTCCCCGGACGTGGAGGTCGCGGCCGTCGCCAGTCGTGACCGGGGCCGGGCCGAGAAGACGGCCGGGCGCTTCGGCTGCCGGCCCGTCCACGGGTACGAGGCGCTGCTGGAGGCCGATGACGTGCAGGCGGTGTACGTGCCGCTGCCGGCCGCTCTGCACGCGCCCTGGGTCGAGGCGGCGCTCGCGGCCGGCAAGCACGTGCTCGCCGAGAAGCCCCTGACGACGGACCCGGACACCACCGCACACCTGCTGAATCTGGCCACCGAGCGGGGCGTGGCACTGATGGAGAACGTGATGTTCGTCCACCACCCCCGGCACGAGGCGGTACGGCGCCTCGTCACCGACGGGCGGATCGGCGAACTCCGCGCGTTCCACGCGGCGTTCACCATTCCTCCGCTCGCTGACAGCGACATCCGGTACGACGCCGGCCTCGGCGGCGGCGCCCTGGCGGACGTCGGCCTCTATCCGCTGCGCGCCGCATTGCACTTCCTGGGCCCGGAGCTCGAGGTGATCGGTGCCCGGACGGTTCGGGGACGCGGACGGCAGGTCGAGACGTCCGGTGCGGCGCTGCTCGGGACTCCCGGCGGAGTCACCGCGCACATCACGTTCGGCATGGAGCACGCCTATCTGTCGCGGTACGAACTGTGGGGCAGCGAAGGGCGGATCACCGTGGACCGGGCGTTCACCCCGCCGGCCGACTTCGTCCCGCCGGTCTCCCTGCACACGTCCGCGGGCACGGAGGAGATCCGGCTGACGCCCGCCGACCAAGTGGCGGCGACGGTCGCCGCCTTCGTCACCGCGGTCCGGGCCGGATACGCGCCGGGCGAGGACACACTGCGGCAGGCCGTTCTGCTGGACGCCGTACGCCGTCGGTCCGGGTGA	MSAPVSIGVLGCADIAVRRMLPAFTASPDVEVAAVASRDRGRAEKTAGRFGCRPVHGYEALLEADDVQAVYVPLPAALHAPWVEAALAAGKHVLAEKPLTTDPDTTAHLLNLATERGVALMENVMFVHHPRHEAVRRLVTDGRIGELRAFHAAFTIPPLADSDIRYDAGLGGGALADVGLYPLRAALHFLGPELEVIGARTVRGRGRQVETSGAALLGTPGGVTAHITFGMEHAYLSRYELWGSEGRITVDRAFTPPADFVPPVSLHTSAGTEEIRLTPADQVAATVAAFVTAVRAGYAPGEDTLRQAVLLDAVRRRSG	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	80.56	gnl|BL_ORD_ID|1210|hsp_num:0	1313			792	987	tigecycline; tetracycline
BGC0000229.1|Grincamycin_32 # 32089 # 33624 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.686	BGC0000229.1|Grincamycin_32 	32089	33624	+	Loose	800	29.261	msrA	28.89	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGACGGTCGAACTGCACGAGATCCGTGCGCAGGCACTGGCCGGCCCGAGCGAGAAGGCGACCCAGGCGCAGCACGCCAAGGGCAAGCTGACCGCGCGGGAGCGCATCGAACTGCTGCTGGACGCGGGTTCCTTCCGTGAGATCGAGCAGTTGCGCCGGCACCGGGCCACCGGCTTCGGTCTGGAGGAGAGGAAGCCGTACACCGACGGTGTGATCACGGGCTGGGGGACGGTGGAGGGGCGGACGGTGTTCGTCTACGCCCACGACTTCCGTATCTTCGGCGGCGCGCTGGGCGAGGCGCATGCCACGAAGATCCACAAGATCATGGACATGGCCATCGCGGCGGGGGCGCCGCTGGTGTCGCTGAACGACGGTGCGGGCGCGCGGATCCAGGAGGGGGTGTCGGCGCTCGCGGGGTACGGGGGCATCTTCCAGCGCAACACCAAGGCGTCGGGCGTGATCCCGCAGATCTCGGTGATGCTGGGCCCGTGCGCGGGCGGTGCGGCCTACAGTCCGGCGCTGACGGACTTCGTGTTCATGGTGCGGGAGACCTCGCAGATGTTCATCACGGGTCCGGACGTGGTCAAGGCGGTCACGGGTGAGGAGATCACCCAGAACGGCCTGGGCGGCGCGGACGTGCACGCCGAGACGTCCGGTGTGTGTCACTTCACGTACGACGACGAGGAGACCTGCATCGCCGAGGTGCGCTACCTGCTGTCCCTGCTGCCGCAGAACAACCGGGAGAACCCGCCGCGGGTGGACTGCTCCGACGCCGCGGACCGGCGCAGCGAGGTGCTGCTGGACCTGGTTCCGGCGGACGGCAACCGGCCGTACGACATGGCGAAGGTGATCGAGGAGATCGTCGACGACGGCGAGTTCCTCGAGGTCCACGAGCGGTGGGCGCGGAACATCATCTGTGCGCTGGCGCGGATGGACGGCCAGGTCGTGGGGATCGTCGCCAACCAGCCGCAGGCGCTGGCGGGTGTGCTGGACATCGAGGCCAGCGAGAAGGCCGCCCGTTTCGTGCAGATGTGCGACGCGTTCAACATCCCGATCCTGACCTTCCTGGACGTGCCCGGCTTCCTGCCGGGTGTGGACCAGGAGCACGGCGGCATCATCCGCCACGGCGCGAAGCTGCTGTACGCGTACTGCAACGCCACGGTGCCGCGGATCTCGCTGATCCTGCGCAAGGCGTACGGCGGTGCGTACATCGTGATGGACAGCCAGTCCATCGGCGCCGACCTGACGTACGCGTGGCCGACGAACGAGATCGCGGTGATGGGCGCGGAGGGCGCGGCGAACGTGATCTTCCGCCGGCAGATCGCCGAGGCCGAGGACCCCGAGGCGATGCGGGCGCGGATGGTCAAGGAGTACAAGTCCGAGCTGATGCACCCCTACTACGCCGCCGAGCGGGGGCTGGTCGACGACGTGATCGACCCGGCCGCCACCCGTGAGGTGCTGATCCGTTCGCTGGCGATGCTGCAGACCAAGCACGCCGACCTGCCGTCGCGCAAGCACGGCAACCCGCCCCAGTAA	MTVELHEIRAQALAGPSEKATQAQHAKGKLTARERIELLLDAGSFREIEQLRRHRATGFGLEERKPYTDGVITGWGTVEGRTVFVYAHDFRIFGGALGEAHATKIHKIMDMAIAAGAPLVSLNDGAGARIQEGVSALAGYGGIFQRNTKASGVIPQISVMLGPCAGGAAYSPALTDFVFMVRETSQMFITGPDVVKAVTGEEITQNGLGGADVHAETSGVCHFTYDDEETCIAEVRYLLSLLPQNNRENPPRVDCSDAADRRSEVLLDLVPADGNRPYDMAKVIEEIVDDGEFLEVHERWARNIICALARMDGQVVGIVANQPQALAGVLDIEASEKAARFVQMCDAFNIPILTFLDVPGFLPGVDQEHGGIIRHGAKLLYAYCNATVPRISLILRKAYGGAYIVMDSQSIGADLTYAWPTNEIAVMGAEGAANVIFRRQIAEAEDPEAMRARMVKEYKSELMHPYYAAERGLVDDVIDPAATREVLIRSLAMLQTKHADLPSRKHGNPPQ	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	104.71	gnl|BL_ORD_ID|1105|hsp_num:0	1200			42	177	erythromycin; quinupristin
BGC0000229.1|Grincamycin_33 # 33640 # 33831 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.755	BGC0000229.1|Grincamycin_33 	33640	33831	+	Loose	375	23.0978	IMP-93	50.0	3007463	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGACGACACCTGACATCCGTGTGGAGAAGGGGCATGCCGAGCCGGAGGAGGTCGCGGCGATCGCGGCGATCCTGATGGCCCGCGCCGCCAACGCGCCCGCCGCAACGCCGGCCCACCGGGGCCGCCCCCGGGCCGGCTGGCGCCGCCTGGAACGCGAACCAGGCTTCCGAGCCCCCCACAGCTGGCGCTGA	MTTPDIRVEKGHAEPEEVAAIAAILMARAANAPAATPAHRGRPRAGWRRLEREPGFRAPHSWR	MKKLFVLCIFLFCSITAAGESLPDLKIEKLEDGVYVHTSFEEVNGWGVFAKHGLVFLVNTDAYLIDTPFAAKDTEKLVNWFVERGYKIKGSISSHFHSDSSGGIEWLNSQSIPTYASELTNELLKKNGKVQAKNSFSGVSYWLLKNKIEIFYPGPGHTQDNVVVWLPEKKILFGGCFVKPYGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDVGDASLLKLTWEQAVKGLKESKKPSQPSN	25.61	gnl|BL_ORD_ID|4959|hsp_num:0	5952			591	645	
BGC0000229.1|Grincamycin_34 # 34188 # 35738 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000229.1|Grincamycin_34 	34188	35738	+	Loose	1800	28.4906	MexD	46.43	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCCGGCGCTGCCGCGGGCTTCGCCGCACTGCCCCATTCGGCGCCCGCCCGGGCCGCCGGACGGATCGCGCCGGAGGTTGTCGTCAGGCCGGGAGACGCCCGGTACGCCGAGCTCGCGGAGCGCGGGTACAACAACCGTTTCGTGGCCACCCCGGACGAGATCTGGCTCGTGCACAGCGCCGCTCAGGTGGAGAAGGCGGTGAACCAGGCCGTCGCCGACAACCAGCGTGTCACGGTGCGCAGTGGAGGTCACTGCTTCGAGGGCCTCGTGGACGACCCGCAATTCCGTCTCCTGGTCGACCTGTCCGAGATGAGGGGCATCAGCTTCGACCCGAAGATGAACGCCTTCGCCGTCGAGGCGGGCGCCCGGCTCGGCGAGGTCTACAAGGCCCTGTACGAGGGCTGGGGGGTGACCGTCCCCGGTGGTGTCTGCCCGGAGGTCGGCGTGGGCGGCCACGTCAGCGGCGGTGGATACGGGCCGCTGTCACGCAGGTACGGCCTGGTCGTGGACCATCTGTACGCCGTCGAGGTCGTGGTCGCGGACCGGCGACGCGGGGCACGGACGATCGTCGCCACCCGGGACGCCGTCGATCCGAACCGCGACCTGTGGTGGGCCCACACAGGCGGCGGTGGCGGCGGGTTCGGCATCGTCACGCGTTTCTGGTTCCGGACGCCGGGTGCCTCCGGCCGTCCCTCCGCGCTCCTGCCGAAGCCGCCGGCCCGGATGCGTAAGACCGTCGTGAGCTGGCCGTGGAGCGAGCTGACCGAGGCTCGTTTCACGCGTCTGGTGCTCAACCACGGAGCCTGGCACGCGGCGAACAGCGCGCCGGGCTCCGAGTACTCGGTGATGCACAGCTCCCTCCAGCTCCACTCCTCGATCACCGGCACGATCGAGCTGGAGATCCGCATGGACGCCACTCTGCCCCGTACATCCCAGCTCCACGACGACTACATCCGCGCGGTGAACGCGGGCGTGGGCCTGGAGCCGACCGTCGACATCACCGAGGGCTCCTGGCTGGACGTCACGCTGGAGCCGACTCCCAGTTACGGCGACTACGGGCGCCAGAAGTCGATGGGCGGACATCTGCGGAAGCCGCTGACCGAAAGCCAGGTCCGCGCGCTCCACCGTTCACTGAGCGACCCCTCCCACTTCGGCGCCGGCCTGGTCTATCTCGCTGCCTACGGCTGCCGCATCAACACGGTTCAGTCCTCCGCCACCGCCATCCCCCAGCGGGACTCCGTCTTCAAGCTCTGGTACTCCAACAACTGGGCGGACCCCGCCCAGGACGACTACGAGGTCGAGTGGCTGCGCACCCTGCGCAAGAACGTGCACGGCGCAACCGGCGGCTTCCCGGTACCCGACGGCCGGCAGGACGGCGGCTACATCAACTACCCCGACGTCGACATGCTCGACCCGGCGCAGAACACCTCGGGTGTGCCCTGGTACTCGATCATCTGGAAGGACAACTACCCGAGGCTGCAGCGCGTCAAGAACACCTACGACCCCCACAACGTCTTCCGGCATGCCATGTCCCTGACCCCCTCCTGA	MAGAAAGFAALPHSAPARAAGRIAPEVVVRPGDARYAELAERGYNNRFVATPDEIWLVHSAAQVEKAVNQAVADNQRVTVRSGGHCFEGLVDDPQFRLLVDLSEMRGISFDPKMNAFAVEAGARLGEVYKALYEGWGVTVPGGVCPEVGVGGHVSGGGYGPLSRRYGLVVDHLYAVEVVVADRRRGARTIVATRDAVDPNRDLWWAHTGGGGGGFGIVTRFWFRTPGASGRPSALLPKPPARMRKTVVSWPWSELTEARFTRLVLNHGAWHAANSAPGSEYSVMHSSLQLHSSITGTIELEIRMDATLPRTSQLHDDYIRAVNAGVGLEPTVDITEGSWLDVTLEPTPSYGDYGRQKSMGGHLRKPLTESQVRALHRSLSDPSHFGAGLVYLAAYGCRINTVQSSATAIPQRDSVFKLWYSNNWADPAQDDYEVEWLRTLRKNVHGATGGFPVPDGRQDGGYINYPDVDMLDPAQNTSGVPWYSIIWKDNYPRLQRVKNTYDPHNVFRHAMSLTPS	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	49.47	gnl|BL_ORD_ID|1485|hsp_num:0	1523			2136	2220	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000229.1|Grincamycin_35 # 35813 # 36250 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.701	BGC0000229.1|Grincamycin_35 	35813	36250	+	Loose	750	27.335	tet(33)	35.29	3000478	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCAGCAGTAACCCCGCTGCCAGCCACACCGCTTCAGGACGCCGTGCGTTGCCCGTGTGGCAGGCGGTGGCGGGGGCCGCCGTCGTCGCCGCCGTCGTCAATCTCGTCGTTCTGTTCATCGGCGATGCCGCCGGGGCCTCACTGGTCCTGGAACTCAACGGCAAGCCCGACGAGATCGGCGCCGGCGACGTCGTCTTCATGTCGGTCGCCGCGCCGGTGCTCGGCATCACCGCGGCCGTTCTCCTGGCCCGCTGGAAGCCGGTGTTCCTGCGGGTGGGCCAGATCGTGGGCGGTTCCGTCGCGGTACTCACCGCGATCGGCCCGCTGACTCAGGAGACCGACGGTGGTACGGCCGCGACACTGATCACGATGCACCTGTTCGTGGGGCTCGTCGCGGTGGCCGCCCTGGAGGCGATTCGGCGGTCCCGCGTCTGA	MTSSNPAASHTASGRRALPVWQAVAGAAVVAAVVNLVVLFIGDAAGASLVLELNGKPDEIGAGDVVFMSVAAPVLGITAAVLLARWKPVFLRVGQIVGGSVAVLTAIGPLTQETDGGTAATLITMHLFVGLVAVAALEAIRRSRV	MSSLTSARGSLATVLITASLDAAGMGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAGITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQTLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTTIFALTYINADGFLWLCAAALYVPCVILIMRGTAASPKFGSWASGDSM	35.63	gnl|BL_ORD_ID|1926|hsp_num:0	2046			573	774	tetracycline
BGC0000229.1|Grincamycin_36 # 36425 # 36880 # -1 # ID=1_36;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	BGC0000229.1|Grincamycin_36 	36425	36880	-	Loose	400	114.775	vanR gene in vanM cluster	39.49	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGCCGATCATCGTCGTGACGGCCCGCGACTCCGAACTCGACCGCGTCATGAGCCTGCGCGCCGGCTCGGACGACTATGTCCCGAAGCCGTACAGCCTGGCCGAACTGATTGCCCGTATCGAGGCGGTCATGCGACGGGCTGTGCGACAGCCGGCCTCGCCTGACGAGGTCGTCGTCGTGGGGCCGCTTTCCATAGACCCCCGGGCCCGCGAAATCCGCCTGGACGACCGGACCATAGAGGTCACGCGCAAGGAATTCGACCTTCTGTATCTGCTCGCCTCACGCCCGGGAATCGTTGTCACCCGGGAGCAGATCATGGTGCAGGTGTGGCGTGACTCCCGGTCCGTGCCGGGGCGGACCATCGACACCCATGTCAGCAGTCTGCGTAGCAAGCTGGGATCGAGCGACTGGATCGTCACCGCTCGAGGAGTCGGATTTCGTCTGGGGCGTGCCTGA	MPIIVVTARDSELDRVMSLRAGSDDYVPKPYSLAELIARIEAVMRRAVRQPASPDEVVVVGPLSIDPRAREIRLDDRTIEVTRKEFDLLYLLASRPGIVVTREQIMVQVWRDSRSVPGRTIDTHVSSLRSKLGSSDWIVTARGVGFRLGRA	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	65.09	gnl|BL_ORD_ID|4735|hsp_num:0	752			222	693	vancomycin; teicoplanin
BGC0000229.1|Grincamycin_37 # 37339 # 37617 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.588	BGC0000229.1|Grincamycin_37 	37339	37617	+	Loose	280	22.3274	emrR	46.67	3000516	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTGCAGGCGATTCGGCACCCGAATGGACGACGCGACCTTTAACGACCGGGCCACCCGGTCGACCGCCGCACCCACGCCCGTCCATCAACTGTCGAACAGTCAACCAACACCGACCCCCCGCGCAGACCTGTCCCACCCTCGCGTGATACATCGTACACGGGGCCGCGTACTGCGTACACGAGGGATGAATCACACCTTGTTCGATCATGGATCGAATCAAGGACAAGCCACCTGCGAAAACACCCTATCCACGTTAAACACTCAAAAGCAGTGGTGA	MCRRFGTRMDDATFNDRATRSTAAPTPVHQLSNSQPTPTPRADLSHPRVIHRTRGRVLRTRGMNHTLFDHGSNQGQATCENTLSTLNTQKQW	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	52.27	gnl|BL_ORD_ID|1225|hsp_num:0	1330			129	174	nalidixic acid
BGC0000229.1|Grincamycin_38 # 37694 # 39598 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0000229.1|Grincamycin_38 	37694	39598	+	Loose	375	30.0314	fusC	22.88	3003733	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	ATGATCTCTACTGAGACACCGGAAAGCGGCAGCAACCGGCTCCGGAGAGGTGACGTCCGCCGGCTCGACCGAGTGATCATCAGGTTCGCGGGGGACTCGGGTGACGGGATGCAGCTCACCGGTGACCGTTTCACCTCGGAGACCGCGTCCTTCGGCAACGACCTCTCCACGCTGCCGAACTTCCCCGCCGAGATCCGCGCCCCCGCCGGCACCCTGCCGGGTGTGTCGTCGTTCCAGCTGCACTTCGCCGACCACGACATCCTCACGCCCGGTGACGCGCCGAACGTGCTGGTGGCGATGAACCCGGCCGCGCTGAAGGCGAACATCGGCGACCTGCCGCGCGGGGCGGAGATCATCGTCAACACCGACGAGTTCACCAAGCGGGCGATGCAGAAGGTCGGCTACGACGCCAGCCCGCTGGAGGACGGCTCGCTGGACGGCTACCACCTGCACCCGGTGCCGCTGACCACGCTGACGGTGGAGGCGCTGAAGGATTTCGACCTCACCCGGAAGGAGGCCGAGCGCAGCAAGAACATGTTCGCGTTGGGTCTGCTGTCGTGGATGTATCACCGGCCGACGGAGGGGACGGAGAAGTTCCTGCGGTCGAAGTTCGCGAAGAAGCCGGACATCGCGGCGGCGAACATCGCGGCGTTCCGGGCGGGCTGGAACTTCGGGGAGACGACGGAGGATTTCGCGGTCTCCTACGAGGTGGCGCCGGCGGCGGCGGCGTTCCCGCCGGGCGTCTACCGCAACATCTCCGGGAATCTGGCCCTGTCGTACGGGCTGATCGCGGCCTCGCGTCAGGCGGACCTGCCGCTGTTCCTGGGCTCGTATCCGATCACTCCGGCCTCGGACATCCTGCACGAGCTGAGCCGGCACAAGAACTTCGGTGTGCGCACGTTCCAGGCGGAGGACGAGATCGCCGGGATCGGGGCGGCGCTGGGGGCGGCGTTCGGCGGGTCGCTGGCGGTGACCACCACCTCCGGTCCGGGTGTGGCGCTGAAGTCGGAGACGATCGGGCTTGCGGTGTCGTTGGAGCTGCCGCTGCTGGTGGTGGACATCCAGCGTGGCGGCCCGTCGACCGGGCTGCCGACGAAGACGGAGCAGGCGGATCTGCTGCAGGCGATGTACGGCCGTAACGGTGAGGCGCCGGTGCCGGTCGTCGCCCCGCGCACGCCGGCGGACTGTTTCGACGCGGCGCTGGAGGCGGCGCGGATCGCGCTGGCCTACCGCACCCCGGTGTTCCTGCTCTCGGACGGGTATCTGGCCAACGGCAGCGAGCCGTGGCGGATCCCGGAGCTGGAGGAGCTGCCGGATCTGACGGTGCAGTTCGCGCAGGGCCCCAACCACACCACCGCCGACGGCGCGGAGGTGTTCTGGCCCTACAAGCGCGACCCGCACACCCTGGCCCGCCCCTGGGCGGTCCCGGGGACGCCGGGATTGGAGCACCGGATCGGGGGCATCGAGAAGCAGGACGGCACCGGGAACATCTCCTACGACCCGGCCAACCACGACTTCATGGTCCGCACCCGCCAGGCCAAGGTCGACAGCATCACCGTGCCCGACCTCGACGTGGACGACCCGGACGGCACCGCCCGCCTGCTCGTCCTCGGCTGGGGCTCGACGTACGGGCCGATCACCGCGGCGGTACGGCGCCTGCGGAAGGCCGGGCAGCCGGTCGCGCAGGCCCACCTGCGCCACCTCAACCCCTTCCCGAAGAACCTCGGCGAGATCCTCACCCGATACGAGCGGATCGTCGTGCCCGAGATGAACCTCGGCCACCTGGCGCTGCTGCTGCGCGCCGGGTATCTGGTCGATGTCCGTTCCCACCACCAGGTCAACGGCATGCCGTTCAAGGCGGAGCAGCTCGCCGACGCACTGCGGGAGATCCTCGATGAGAACTGA	MISTETPESGSNRLRRGDVRRLDRVIIRFAGDSGDGMQLTGDRFTSETASFGNDLSTLPNFPAEIRAPAGTLPGVSSFQLHFADHDILTPGDAPNVLVAMNPAALKANIGDLPRGAEIIVNTDEFTKRAMQKVGYDASPLEDGSLDGYHLHPVPLTTLTVEALKDFDLTRKEAERSKNMFALGLLSWMYHRPTEGTEKFLRSKFAKKPDIAAANIAAFRAGWNFGETTEDFAVSYEVAPAAAAFPPGVYRNISGNLALSYGLIAASRQADLPLFLGSYPITPASDILHELSRHKNFGVRTFQAEDEIAGIGAALGAAFGGSLAVTTTSGPGVALKSETIGLAVSLELPLLVVDIQRGGPSTGLPTKTEQADLLQAMYGRNGEAPVPVVAPRTPADCFDAALEAARIALAYRTPVFLLSDGYLANGSEPWRIPELEELPDLTVQFAQGPNHTTADGAEVFWPYKRDPHTLARPWAVPGTPGLEHRIGGIEKQDGTGNISYDPANHDFMVRTRQAKVDSITVPDLDVDDPDGTARLLVLGWGSTYGPITAAVRRLRKAGQPVAQAHLRHLNPFPKNLGEILTRYERIVVPEMNLGHLALLLRAGYLVDVRSHHQVNGMPFKAEQLADALREILDEN	MNKIEVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKDIDISDFITSIDDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFRKVKKLKRPDINLIDTKEISYLGWNDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTYTKKGDYICYDSFKCNQNLDDINNLYEFIVKIK	299.06	gnl|BL_ORD_ID|2067|hsp_num:0	2250			168	507	fusidic acid
BGC0000229.1|Grincamycin_39 # 39588 # 40613 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.692	BGC0000229.1|Grincamycin_39 	39588	40613	+	Loose	500	29.261	CTX-M-80	31.17	3001941	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAGAACTGAACTGCGCCTGTCCGCCAAGGACTTCAAGTCCGATCAGGAGGTGCGCTGGTGCCCGGGCTGCGGTGACTACGCCGTGCTGGCCGCCATGCAGGGCTTCATGCCGGAACTGGGCCTGGCCCGGGAGAACATCGTGTTCGTCTCCGGCATCGGCTGCTCCTCCCGCTTCCCGTACTACATGAACACCTACGGGATGCACTCCATCCACGGCCGCGCCCCCGCCATCGCCACCGGCCTCGCCACCTCCCGCCGCGACCTGAGCGTGTGGGTCGTCACCGGCGACGGCGACGCGCTGTCCATCGGCGGCAACCACCTCATCCACGCCCTGCGCCGCAACGTCAACCTCAAGATCCTGCTGTTCAACAACCGCATCTACGGCCTCACCAAAGGCCAGTACTCCCCCACCTCCGAGGTCGGCAAGATCACCAAGTCGACCCCGATGGGCTCGCTCGACGCGCCCTTCAACCCCGTCTCGCTGGCCATCGGCGCCGAGGCGTCCTTCGTCGCCCGCACCGTCGACTCCGACCGCAAACACCTCACCGAAGTGCTGCGCCAGGCCGCCGGCCACCCGGGCACGGCGCTGGTGGAGATCTACCAGAACTGCAACATCTTCAACGACGGCGCCTTCGAGGTCCTCAAGGACCGCCGACAGGCCGAGGAAGCCGTCATCCGCCTCGAGCACGGGCAGCCGATCCGCTTCGGCGCCGACGGCTCCAAGGGCGTGGTCCGCGACCCGGCCACCGGTGACCTGAAGGCCGTCGCCGTCACACCCGGCAACGAGGCGGACATCCTCGTCCACGACGCCCACAACCCGTCCCCGACGACCGCGTTCGCCCTGTCCCGGCTCGCCGACCCCGACACCCTGCACCACACCCCCATCGGCGTGTTCCGCTCCGTCGACCGGCCCGTCTACGACACCCTCATGGCCGACCAGCTCGACACCGCCGTCGACCAGCACGGCAAGGGCGACCTCGCCGCACTCCTCGCCGGCGGCGACACCTGGACCGTCGCCGGCTGA	MRTELRLSAKDFKSDQEVRWCPGCGDYAVLAAMQGFMPELGLARENIVFVSGIGCSSRFPYYMNTYGMHSIHGRAPAIATGLATSRRDLSVWVVTGDGDALSIGGNHLIHALRRNVNLKILLFNNRIYGLTKGQYSPTSEVGKITKSTPMGSLDAPFNPVSLAIGAEASFVARTVDSDRKHLTEVLRQAAGHPGTALVEIYQNCNIFNDGAFEVLKDRRQAEEAVIRLEHGQPIRFGADGSKGVVRDPATGDLKAVAVTPGNEADILVHDAHNPSPTTAFALSRLADPDTLHHTPIGVFRSVDRPVYDTLMADQLDTAVDQHGKGDLAALLAGGDTWTVAG	MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	117.18	gnl|BL_ORD_ID|1190|hsp_num:0	1297			48	273	
BGC0000229.1|Grincamycin_40 # 40666 # 40932 # -1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000229.1|Grincamycin_40 	40666	40932	-	Loose	450	23.8682	cphA6	28.89	3003102	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGAGCAGCGACCGCGAGCGAGACGGGACCCGGCCCACCGAGCTGCAGTGCGCCGCGTGCGGCCGGCCGGTGGAGACCGTCGTCACCCGGCACAAGACCTTCGGCATCAACGTCCCCCAGTGGCGGGCGGGCCCCTGCCACAACCCCGACTGCCCGGACTACGTCCCCGAGCTGGTCCCGGCGGACGCCCTCCGCCACAGGGCGGGGGAGGAGCAGGCGGAGCGGCGACAGGAGGAACGCGAGAAGGAGACCGGCCCGCCCGCCTGA	MSSDRERDGTRPTELQCAACGRPVETVVTRHKTFGINVPQWRAGPCHNPDCPDYVPELVPADALRHRAGEEQAERRQEEREKETGPPA	MMKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEELIKAAAHS	34.65	gnl|BL_ORD_ID|1800|hsp_num:0	1949			654	756	
BGC0000229.1|Grincamycin_41 # 40953 # 41909 # -1 # ID=1_41;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	BGC0000229.1|Grincamycin_41 	40953	41909	-	Loose	2200	25.7942	Bifidobacterium bifidum ileS conferring resistance to mupirocin	35.71	3003730	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	GTGCATGACGTGCCGTTCTGGCTGTGGGCCGTGTTCGTCGTCATCGTCGTCGTGTCCCTCGCCGTCGACCTGTTCGCGCACCGCTCCGCCCACGCCATCGGCTTCCGTGAGGCCACCGCGTGGAGCGTCGCGTGGATCTCCCTGGCCATCCTCTTCGGCGGGGTGGTCTTCCTCGTCGTCGGCACCGACGCGGGCGTGGAGTACACCACCGCGTGGCTGCTGGAGAAGAGCCTGTCCGTCGACAACCTCTTCGTCTTCGCGTTGATCTTCAGCTACTTCCAGGTGCCACGCGCCTACCAGCACCGTGTGCTGTTCCTCGGCGTCCTGGGCGCCCTGGTCTTCCGCGGCCTGTTCCTCGCCGCCGGCGTGGCCGTGGTCAGCCGCTTCACCGCCGTGCTGTTCGTCTTCGCGGCGATCCTCTTCTGGAGCACGTACAAGATCCTCAAAGGGGAGGACGAGAGCTTCGACCCGGGCAAGAGCCTGGCGGTCCGGCTGCTGCGCAAGGTGATCCCGGTCCGGGACGAGTACGCGGGCGCGCACTTCTTCGTCAAGGAGGCGGGCAAACGGGTGGCGACCCCGCTGCTCGCGGTCGTCGCCGCCATCGAGGCCGCCGACCTGGTCTTCGCCGTCGACAGCGTGCCCGCCGTCCTCGCCGTCAGCAGCGACGTCTTCATCGTCTACACCAGCAACGCCTTCGCCATCCTCGGCCTGCGCGCCCTGTACTTCATGCTGGCCGGCCTCCTCGACCGCTTCCACTACCTCAGTGTCGGCCTCGCGGTGATCCTCGGCTTCATCGGCGTCAAGCTGGTGCTCCAGGCGACCCACGAGACGATCACCACCGCCGTCCCGGAGATCCCGTCCCTGGTCAGCCTGGCCGTGATCGTCGTCGTCCTGGCCGTGTCGATCACGGTGAGCGTGCTGCGGCCACCGGCCGCCGAACAGGACAAAACCGTGTAA	VHDVPFWLWAVFVVIVVVSLAVDLFAHRSAHAIGFREATAWSVAWISLAILFGGVVFLVVGTDAGVEYTTAWLLEKSLSVDNLFVFALIFSYFQVPRAYQHRVLFLGVLGALVFRGLFLAAGVAVVSRFTAVLFVFAAILFWSTYKILKGEDESFDPGKSLAVRLLRKVIPVRDEYAGAHFFVKEAGKRVATPLLAVVAAIEAADLVFAVDSVPAVLAVSSDVFIVYTSNAFAILGLRALYFMLAGLLDRFHYLSVGLAVILGFIGVKLVLQATHETITTAVPEIPSLVSLAVIVVVLAVSITVSVLRPPAAEQDKTV	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	28.73	gnl|BL_ORD_ID|4694|hsp_num:0	2278			2619	2745	mupirocin
